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ABSTRACT	
Nup358	 is	 the	 largest	 nucleoporin	 of	 around	 358	 kDa	 molecular	 weight	 that	
localizes	on	the	cytoplasmic	face	of	the	nuclear	pore	complex	(NPC).	It	takes	part	in	the	
overall	activity	of	the	NPC	mediating	the	transport	of	nucleic	acids	and	proteins	between	
the	nucleus	and	the	cytoplasm.	However,	due	to	its	multi-domain	configuration,	Nup358	
has	 a	more	 pleiotropic	 function	 in	 several	 cellular	mechanisms	 such	 as	mediating	 the	
stability	 of	 microtubules	 and	 axon	 specification.	 Since	 little	 is	 known	 about	 the	 non-
conventional	 role	 of	 Nup358	 in	 neuronal	 polarity,	 my	 PhD	 thesis	 was	 focused	 on	
characterizing	the	subcellular	distribution	and	expression	pattern	of	Nup358	protein	 in	
cultured	neurons.	My	results	show	Nup358	present	at	the	nuclear	rim	of	neuronal	cells,	
associated	with	NPCs,	also	in	the	cytoplasm	having	a	spotted	pattern	along	the	neuronal	
processes.	 Interestingly,	Nup358	was	 remarkably	 clustered	at	 the	axon	 initial	 segment	
(AIS)	 of	 mature	 neurons	 and	 dependent	 on	 a	 prior	 recruitment	 of	 the	 master	 AIS	
scaffold,	 Ankyrin-G	 (AnkG),	 to	 this	 specific	 region.	 Of	 the	 distinct	 domains	 present	 in	
Nup358	protein,	the	N-terminal	region	was	found	to	be	crucial	for	its	localization	at	the	
AIS.	 Further,	 changes	 in	 Nup358	 protein	 expression	 were	 monitored	 during	 neuronal	
development.	Indeed,	I	detected	the	presence	of	a	shorter	isoform	of	Nup358	that	was	
increasing	 as	 neurons	 develop	 whereas	 the	 full-length	 protein	 had	 an	 opposite	
decreasing	trend.	To	gain	knowledge	about	the	functional	role	of	Nup358	in	neurons,	 I	
investigated	 its	 protein	 expression/distribution	 in	 response	 to	 an	 increasing	 or	
decreasing	neuronal	activity	with	specific	drug	treatments.	Surprisingly,	Nup358	protein	
expression	 was	 reduced	 following	 the	 stimulation	 or	 the	 depolarization	 of	 neurons,	
mediated	by	calcium	influx	and	NMDA	receptors.	Overall,	my	results	show	that	Nup358	
has	a	unique	subcellular	distribution	in	neurons,	being	enriched	at	the	AIS	at	advanced	
stages	 of	 development,	 therefore,	 suggest	 an	 involvement	 of	 Nup358	 protein	 in	
maintaining	and	modulating	neuronal	polarity	and	activity.		
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1. INTRODUCTION	
1.1. An	overview	of	the	nuclear	pore	complex	
The	 nuclear	 envelope	 (NE)	 is	 a	 double	 membrane	 that	 encloses	 the	 genetic	
material	 inside	 the	 nucleus	 and	 represents	 a	 physical	 barrier	 for	 contact	 with	 the	
cytoplasm.	By	 this	compartmentalization	 in	eukaryotic	cells,	 the	NE	not	only	separates	
the	 nucleus	 from	 the	 cytoplasm	 but	 also	 adds	 one	 level	 of	 regulation	 for	 gene	
expression,	that	is	absent	in	prokaryotic	cells.	However,	exchange	of	molecules	between	
the	nucleus	and	the	cytoplasm	is	essential	for	maintaining	cellular	metabolism.	Nuclear	
proteins	 such	 as	 DNA	 polymerases,	 RNA	 polymerases,	 RNA-processing	 proteins,	
transcription	factors	and	histones,	all	are	proteins	crucial	for	the	proper	function	of	the	
nucleus	 yet	 are	 synthesized	 in	 the	 cytoplasm.	 In	 contrast,	 virtually	 all	 RNAs,	 including	
mRNAs,	 tRNAs,	 rRNAs,	 and	miRNAs	are	 synthesized	 in	 the	nucleus	and	 transported	 to	
the	cytoplasm.	These	 import/export	pathways	between	the	nucleus	and	the	cytoplasm	
occur	 through	 pores	 of	 the	 NE,	 formed	 by	 the	 fusion	 of	 the	 outer	 and	 inner	 nuclear	
membranes	(Fig.	1-1).	As	the	number	of	pores	present	in	the	NE	can	vary	between	3-5	
NPC/μm2	1,	a	typical	tissue	cell	can	have	roughly	2000–4000	pores	in	its	NE	2.	Occupying	
the	 space	 of	 these	 pores	 are	 large	 multiprotein	 complexes	 known	 as	 Nuclear	 Pore	
Complexes	 (NPCs)	 whose	 main	 role	 is	 to	 mediate	 the	 trafficking	 of	 protein	 and	 RNA	
between	the	nucleus	and	the	cytoplasm	3,4.	
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Figure	 1-1	 |	 A	 cross-section	 of	 a	 typical	 eukaryotic	 cell,	 with	 an	 emphasis	 on	 the	 structure	 of	 the	
nucleus.	 (A)	An	Electron	Micrograph	(EM)	of	a	pancreatic	acinar	cell	showing	the	nucleus	surrounded	by	
the	 nuclear	 envelope	 with	 the	 inner	 and	 outer	 nuclear	 membranes	 (INM	 and	 ONM)	 fused	 at	 certain	
intervals	and	thus	forming	nuclear	pores	that	are	marked	by	arrows.	(B)	Schematic	drawing	of	the	nucleus	
showing	 the	major	 structural	 components:	 the	 condensed	 and	 the	 extended	 regions	 of	 the	 chromatin,	
namely	 the	 heterochromatin	 and	 the	 euchromatin	 respectively,	 the	 nucleolus	 which	 is	 the	 site	 of	
ribosome	biogenesis,	and	the	nuclear	pores	that	traverse	the	NE,	the	latter	of	which	is	continuous	with	the	
endoplasmic	reticulum	(ER)	studded	with	regularly	spaced	ribosomes	(adapted	from	Fawcett	et	al.,	1981	
5). 
Nuclear	pore	complexes	are	the	primary	gateway	for	molecules	to	enter	and	exit	
the	cell	nucleus.	Since	their	discovery	in	the	1950s,	NPCs	have	been	thoroughly	studied	
to	 unravel	 their	 overall	 structure,	 molecular	 composition	 and	 function	 as	 transport	
channels	 between	 the	 nucleus	 and	 the	 cytoplasm.	 The	 NPC	 is	 considered	 one	 of	 the	
largest	protein	complexes	 in	a	cell,	having	a	net	molecular	weight	of	60	MDa	in	yeasts	
and	 approximately	 120-125	MDa	 in	 vertebrate	 cells	 2,6–8.	 Owing	 to	 its	 high	molecular	
weight,	 the	 NPC	 structure	 of	 120	 nm	 diameter	 has	 been	 visualized	 using	 various	
techniques	of	electron	microscopy.	NPCs	were	thus	described	as	channels	traversing	the	
NE,	associated	with	16	protein	 subunits,	eight	on	 the	nucleoplasmic	 side	and	eight	on	
the	cytoplasmic	side	with	radial	symmetry	across	the	nuclear	envelope	9.	This	octagonal	
structure	 of	 the	 NPC	 was	 inferred	 from	 electron	micrographs	 of	 the	 nuclear	 and	 the	
cytoplasmic	surfaces	of	the	NE.	However,	a	more	detailed	picture	of	NPCs	structure	and	
3D-organization	was	only	achieved	through	advancements	in	the	fixation	protocols	and	
microscopy	techniques	such	as	field-emission	in-lens	electron	microscopy,	cryo-electron	
tomography,	 and	 single-particle	 reconstruction	 10–14.	 Altogether,	 studies	 of	 nearly	 60	
A	 B	
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years	 of	 active	 research	 have	 delineated	 NPCs	 ultrastructure	 that	 comprises	 three	
distinct	regions:	the	central	transport	channel	with	an	embedded	scaffold,	and	two	rings	
located	sideways,	one	cytoplasmic	and	the	other	nuclear,	each	is	associated	with	eight	
filaments	 15.	 Whereas	 the	 cytoplasmic	 filaments	 are	 more	 flexible	 having	 their	 loose	
ends	 freely	 protruding	 towards	 the	 cytoplasm	 11,16,	 the	 nuclear	 filaments	 are	 joined	
together	in	a	distal	ring	forming	a	structure	known	as	the	nuclear	basket	(Fig.	1-2).	This	
overall	structure	of	NPCs	is	well-conserved	from	yeast	to	human	even	though	there	are	
considerable	 discrepancies	 in	 the	 protein	 composition,	 density	 and	 size	 of	 the	 NPC	
among	species	17–20.	
	
Figure	1-2	|	The	NPC	architecture.	(A)	An	EM	of	a	cross-section	view	of	an	oocyte	nucleus.	 In	this	view,	
two	NPCs	 are	 identified	 spanning	 the	NE	 21.	 (B)	 A	 schematic	 representation	 of	 the	 consensus	model	 of	
vertebrate	NPC	22.	
1.2. The	nucleoporins	family	
Proteomic	 analyses	 of	 NPC	 protein	 composition	 revealed	 that	 despite	 its	
enormous	 size,	 the	 NPC	 is	 composed	 of	 only	 30	 different	 proteins	 termed	 as	
nucleoporins	6,17,18,23.	Each	nucleoporin	 is	present	 in	8,	16,	32	or	more	copies	per	NPC,	
thus	accounting	for	NPCs	high	molecular	weight	24.	Nomenclature	of	most	nucleoporins	
is	 often	denoted	 as	Nup	 followed	by	 a	number	 corresponding	 to	 its	molecular	weight	
(MW),	 for	 instance,	Nup107	 in	humans	has	a	MW	of	107	kDa	whereas	 its	homolog	 in	
yeast,	Nup84	is	of	84	kDa	MW	15.	
Nucleoporins	are	arranged	in	biochemically	defined	subcomplexes,	i.e.	composed	
of	stably	interacting	nucleoporins,	which	structurally	represent	the	building	blocks	of	the	
NPC	 18.	 In	 fact,	 the	 NPC	 is	 a	 modular	 assembly	 of	 a	 limited	 number	 of	 distinct	
subcomplexes	 25.	 However,	 not	 all	 nucleoporins	 are	 identified	 within	 subcomplexes;	
A	 B	
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such	nucleoporins	might	have	a	more	dynamic	characteristic	or	a	 relatively	 less	 stable	
interaction	 with	 one	 another	 than	 nucleoporins	 belonging	 to	 NPC	 subcomplexes.	
Therefore,	nucleoporins	are	often	grouped	based	on	two	factors,	their	association	within	
subcomplexes	and/or	approximate	localization	in	the	overall	structure	of	the	NPC	(Fig.	1-
3):	1)	the	Y-complex,	also	known	as	coat	nucleoporin	complex	(CNC),	2)	adaptor	protein	
complex	 present	 in	 the	 inner	 ring	 (known	 as	 Nup93/Nic96	 complex),	 3)	 central	
phenylalanine-glycine	 nucleoporins	 (FG-Nups),	 4)	 transmembrane	 nucleoporins	 (TM	
Nups)	 or	 pore-membrane	 proteins	 (POMs),	 5)	 nuclear-basket	 nucleoporins,	 and	 6)	
cytoplasmic-filament	 nucleoporins,	 and	 7)	 a	 final	 category	 that	 includes	 a	 few	
unclassified	nucleoporins	25–27.		
	
	
Figure	 1-3	 |	 Distribution	 of	 nucleoporins	 in	 the	 NPC	 overall	 structure.	 Side	 view	 of	 the	 NPC	 showing	
nucleoporins	grouped	according	to	their	 localization	in	the	NPC	and/or	association	within	subcomplexes.	
Yeast	 nucleoporins	 and	 the	 corresponding	metazoan	 variants	 are	 shown	 side	 to	 side	with	 the	 (-)	mark	
indicating	that	the	homolog	Nup	is	absent	in	the	opposite	species	28.	
The	 Y-complex,	 known	 as	 Nup107-160	 complex	 in	 humans,	 is	 considered	 the	
largest	 and	best	 characterized	NPC	 subcomplex.	Depending	on	 species,	 the	 Y-complex	
includes	6-10	Nups	29–33.	Nucleoporins	of	this	subcomplex	assemble	in	an	elongated	and	
branched	structure	similar	in	shape	to	the	letter	Y,	hence	its	name	the	Y-complex	34–36.	It	
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is	the	scaffolding	unit	that	represents	the	core	of	the	NPC	and	gives	the	NPC	its	peculiar	
shape	37,38.	Thus,	Nups	of	this	complex	are	located	at	the	central	channel	and	at	both	the	
nuclear	and	cytoplasmic	rings	36,39,40.		
The	 second	 main	 structural	 subcomplex	 is	 the	 Nup93/Nic96	 complex	 that	
localizes	at	the	inner	ring	of	the	NPC	41–44.	In	contrast	to	the	Y-complex,	the	Nup93/Nic96	
complex	 is	 less	 studied,	 though	 it	 describes	 a	 complex	 of	 five	 to	 seven	 nucleoporins	
including	 Nup93	 41–43.	 The	 stoichiometry	 of	 nucleoporins	 within	 the	 Nup93/Nic96	
subcomplex	 is	 not	 fully	 elucidated	 45–48,	 thus	 implying	 that	 the	 not	 all	 Nup93/Nic96	
subcomplexes	within	 the	NPC	are	necessarily	 identical.	However,	Nup93	 is	particularly	
an	indispensable	nucleoporin	depletion	of	which	compromises	the	formation	of	both	the	
NPC	 and	 the	 NE	 49.	 Above	 all,	 localization	 of	 Nup93/Nic96	 subcomplex	 en	 masse	 is	
essential	to	recruit	and	anchor	Nup62	subcomplex	to	the	NPC	43.		
Lying	in	the	center	of	the	pore,	Nup62	subcomplex	establishes	NPCs	permeability	
barrier	and	represents	a	key	element	in	the	entire	transport	system	across	the	pore	50.	In	
eukaryotes,	 Nup62	 subcomplex	 is	 formed	 of	 three	 nucleoporins	 belonging	 to	 the	 FG-
Nups	group	46.	These	Nups	are	characterized	by	the	presence	of	up	to	50	phenylalanine-
glycine	repeats	(FG-repeats)	distributed	along	their	protein	sequence	51,52.	 In	structure,	
the	 FG-Nups	 of	 this	 trimeric	 Nup62	 subcomplex	 assemble	 in	 disordered	 fiber-like	
extensions	 protruding	 from	 the	 central	 channel,	 thus	 forming	 the	 hydrogel	meshwork	
that	is	a	permeable	yet	a	selective	barrier	for	the	transport	of	molecules	across	the	NPC	
channel	53–56.	
 Similar	 to	 the	 Y-complex,	 both	 the	 Nup93	 and	 Nup62	 subcomplexes	 serve	 a	
structural	 role	 in	NPCs	 overall	 architecture.	However,	 the	NPC	 scaffold	 is	 anchored	 to	
the	 nuclear	 envelope	 by	 transmembrane	 Nups	 that,	 in	 metazoans,	 include	 the	
nucleoporins	gp210,	Ndc1,	and	POM121	57–59.	These	TM	nucleoporins,	therefore,	localize	
between	the	pore	membrane	and	the	central	framework	of	the	NPC.		
To	 complete	 the	 NPC	 structure,	 the	 nucleoporins	 Nup153,	 Nup50	 and	 Tpr	
assemble	on	 the	nucleoplasmic	side	 in	eight	considerably	 long	 filaments,	 located	∼100	
nm	from	the	plane	of	the	NE,	and	joined	together	in	the	distal	ring	of	the	nuclear	basket	
structure	 60–64.	 On	 the	 other	 side	 of	 the	 NPC,	 the	 nucleoporins	 Nup214	 and	 Nup88	
assemble	in	the	so-called	Nup214	subcomplex	and,	along	with	the	nucleoporin	Nup358,	
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build	the	cytoplasmic	filaments	that	emanate	from	the	NPC	towards	the	cytoplasm	65,66.	
Compared	to	the	nuclear	filaments,	cytoplasmic	filaments	are	shorter,	around	∼35	nm,	
kinky	and	delicate	filaments	14.		
1.3. Dynamic	Nups	
The	NPC,	as	a	whole	entity,	has	a	static	nature,	being	stably	embedded	in	the	NE	
during	 the	 interphase	period.	During	 the	cell	 cycle,	 the	nucleus	changes	 in	shape,	as	a	
result,	NPCs	can	move	 in	arrays	without	having	 inherent	mobility	at	 the	axial	plane	of	
the	 NE	 67.	 Individual	 nucleoporins,	 instead,	 can	 be	 very	 dynamic	 in	 both	 dividing	 and	
non-dividing	cells	68,69.		
Even	though	nucleoporins	comprise	the	NPC	structure,	many	Nups	can	be	found	
in	the	cytoplasm	(or	in	the	ER	as	for	the	transmembrane	nucleoporin	gp210),	and/or	the	
nucleoplasm	69–72.	 In	a	pilot	 study	by	Rabut	et	al.	2004,	19	out	of	 the	30	nucleoporins	
were	 investigated	 for	 their	dynamic	characteristic.	These	19	nucleoporins	were	 tagged	
with	 green	 fluorescent	 protein	 (GFP),	 stably	 expressed	 in	 mammalian	 cells,	 and	
monitored	 for	 their	 dissociation	 rate	 from	 NPCs	 by	 inverse	 FRAP	 (iFRAP).	 iFRAP	 is	 a	
technique	by	which	all	fluorescent	molecules	in	an	entire	cell	are	photobleached	except	
for	 a	 small	 target	 region	 that	 is,	 in	 this	 case,	 the	 NPCs.	 The	 measurement	 of	 a	
nucleoporin	dissociation	rate	from	the	NPC,	or	inversely	its	residence	period	at	the	NPC,	
was	considered	an	indication	of	that	nucleoporin	dynamic	ability.	Results	obtained	were	
variable	 among	 the	 studied	 nucleoporins	 depending	 on	 two	 basic	 parameters:	 1)	 the	
nucleoporin	 localization	 in	the	NPCs	structure	and	2)	 its	 functional	role	 in	NPCs	overall	
activity.	In	brief,	nucleoporins	forming	the	core	of	NPCs	were	relatively	more	stable	than	
peripheral	 nucleoporins	 that	 exhibited	 a	 more	 dynamic	 behavior.	 For	 example,	
nucleoporins	belonging	to	Nup107-160	subcomplex	had	 long	residence	period	of	more	
than	35	hours	69,73	compared	to	Nup153	and	Nup50	of	the	nuclear	basket,	that	are	highly	
dynamic	with	NPC	residence	periods	in	the	minute	range	69,74.			
Indeed,	 this	 study	concluded	that	nucleoporins	can	be	classified	based	on	 their	
dynamic	ability	into	three	classes:	scaffold,	adaptor,	and	dynamic	nucleoporins.	Scaffold	
nucleoporins	 are	 stably	 associated	 with	 NPCs	 and	 have	 low	 dissociation	 rates	 while	
adaptor	nucleoporins	are	relatively	mobile	with	intermediate	dissociation	rates	between	
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the	 scaffold	 and	 dynamic	 nucleoporins.	 Thus,	 the	 last	 class	 corresponding	 to	 dynamic	
nucleoporins	is	characterized	by	Nups	of	high	dissociation	rates;	in	other	words,	they	are	
highly	mobile	 compared	 to	 the	 rest	 of	 the	 studied	 nucleoporins	 69.	Whereas	 scaffolds	
serve	 a	 structural	 role	 in	 the	 NPC,	 dynamic	 nucleoporins	 such	 as	 Nup153	 and	 Nup98	
instead	have	a	functional	role	 in	the	nucleocytoplasmic	transport,	as	they	are	essential	
for	the	export	of	RNA	and	import	of	nuclear	proteins		75,76.		
Up	 to	 now,	 little	 is	 known	 about	 the	 influence	 of	 nucleoporins	 dynamics	 in	
nucleocytoplasmic	 transport	 and	 cell	 physiology.	 However,	 a	 handful	 of	 reports	 have	
identified	the	involvement	of	specific	nucleoporins	in	different	cellular	mechanisms	such	
as	cell	migration,	signaling,	differentiation,	regulation	of	genome	architecture,	and	gene	
expression	4,77–79.	
1.4. Nup358	
Taking	into	consideration	the	reported	dynamic	feature	of	several	nucleoporins,	
especially	 those	 located	 on	 the	 periphery	 of	 the	 NPC,	 Nup358	 represents	 one	 good	
candidate	 worth	 an	 in-depth	 investigation	 for	 its	 dynamic	 behavior.	 Nup358	 resides	
asymmetrically	 on	 the	 cytoplasmic	 filaments	 of	 the	 NPC	 structure	 80.	 Though	 not	
classified	within	a	specific	NPC	subcomplex,	Nup358	interacts	with	the	nucleoporins	co-
localizing	 at	 the	 cytoplasmic	 filaments,	 namely	 Nup214	 and	 Nup88	 81.	 At	 the	 NPC,	
Nup358	has	a	pivotal	role	in	the	nucleocytoplasmic	transport.	However,	a	growing	body	
of	 evidence	 identified	 non-conventional	 roles	 for	 this	 nucleoporin	 depending	 on	 its	
interaction	with	partner	proteins.	
1.4.1. Nup358	structure	at	a	glance	
Nup358	is	a	unique	constituent	of	the	metazoan	NPC	with	no	identified	homolog	
in	yeast.	It	was	originally	identified	as	a	giant	nuclear	pore	protein	that	binds	to	Ran	82,	a	
small	GTP-binding	nuclear	protein,	hence	known	also	as	Ran-binding	protein	2	(RanBP2).	
This	 giant	 protein	 is	 by	 far	 the	 largest	 nucleoporin	 with	 an	 approximate	 molecular	
weight	 of	 358	 kDa	 82,83.	 The	human	Nup358	protein	 sequence	 comprises	 3,224	 amino	
acid	residues	and	includes	a	variety	of	functional	domains	(Fig.	1-4).	Based	on	the	motifs	
it	 harbors,	Nup358	 protein	 can	 be	 divided	 into	 several	 distinct	 regions:	 an	N-terminal	
region	 of	 ~700-residues	 known	 as	 the	 leucine-rich	 region	 (LRR)	 containing	 a	 leucine	
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zipper	 motif,	 four	 homologous	 RanGTP-binding	 domains,	 eight	 tandem	 zinc	 finger	
motifs,	 a	 small	 ubiquitin-like	 modifier	 (SUMO)	 E3	 ligase	 domain,	 and	 a	 C-terminal	
cyclophilin	A	homology	domain	83.	These	domains	are	linked	to	each	other	by	FG-repeats	
of	 the	 xFxFG	 pentapeptide	 sequence	 (where	 x	 represents	 any	 amino	 acid)	 distributed	
over	the	protein	sequence	and	constitute	the	docking	sites	for	transport	receptors	84,85.	
While	 the	 different	 domains	 of	 Nup358	 have	 been	 already	 identified,	 yet	 only	 the	N-
terminus,	 two	 Ran-binding	 domains,	 the	 SUMO	 E3	 ligase	 domain,	 and	 the	 C-terminus	
have	 been	 structurally	 characterized	 86–90.	 Despite	 that,	 the	 so-far	 structure-function	
studies	on	Nup358	have	 identified	an	 increasing	 list	of	proteins	 to	 interact	 specifically	
with	 distinct	 domains	 of	 Nup358	 protein	 sequence	 (see	 Fig.	 1-4);	 thus,	 highlighting	 a	
rather	 intricate	 role	of	Nup358	 in	nucleocytoplasmic	 transport	 and	 the	overall	 cellular	
activity.		
	
Figure	 1-4	 |	 Schematic	 representation	 of	 the	 human	Nup358	protein.	The	 3,224-amino	 acid	 sequence	
comprises	distinct	domains	and	the	corresponding	interacting	proteins.	LRR,	Leucine-rich	region;	RBD,	Ran	
GTP-binding	 domain;	 zinc-fingers	 domain;	 KBD,	 kinesin-binding	 domain;	 IR,	 internal	 repeats;	 CY,	
cyclophilin	A	homology	domain	4.	
1.4.2. Functional	role	in	the	nucleocytoplasmic	transport	
Around	 1	 million	 molecule/min	 crosses	 the	 NE	 of	 a	 metabolically	 active	 cell,	
mediated	 by	 the	 NPC.	 Restricted	 by	 their	 size,	 molecules	 can	 pass	 through	 the	 9-nm	
diameter	pore	 in	 a	passive	diffusion	manner	 91.	 For	 instance,	 small	 sized	molecules	 as	
cytochrome	 c	 (13	 kDa)	 can	 easily	 cross	 the	 NPC,	 while	 ovalbumin	 (43	 kDa)	 is	 slowly	
transported,	 and	 bovine	 serum	 albumin	 (66	 kDa)	 is	 almost	 blocked	 from	 entering	 the	
pore	 91.	On	 the	 other	 hand,	macromolecules	 of	 diameter	 up	 to	 25	 nm	are	 capable	 of	
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crossing	 the	NPC	 through	 active	 transport	 controlled	 by	 the	 following	main	 elements:	
energy	 consumption,	 signal	 dependence	 (nuclear	 localization	 signal;	 NLS	 and	 nuclear	
export	 signal;	 NES),	 transport	 receptors	 mostly	 karyopherins	 (importin	 and	 exportin),	
and	 saturability	 91–93.	 The	 bidirectional	 flow	 of	 molecules	 across	 the	 NPC	 involves	
multiple	proteins	that	are	finely	coordinated	in	elusive	mechanisms.			
In	 theory,	 Nup358/RanBP2	 localization	 at	 the	 NPC	 periphery	 suggests	 its	
involvement	 in	 the	 transport	 of	molecules	 into	 and	out	 of	 the	 nucleus.	Nup358	 could	
interact	 with	 proteins	 to	 be	 imported	 to	 the	 nucleus	 and	 facilitate	 their	 entry,	 and	
oppositely	Nup358	might	contribute	to	the	dissociation	of	cargo	from	the	nucleus	to	the	
cytoplasm.	 In	 fact,	several	 functional	domains	present	 in	Nup358	protein	proved	to	be	
binding	 sites	 for	members	 of	 the	 nucleocytoplasmic	 transport	machinery	 such	 as	 Ran	
83,86.	Ran	participates	in	NPC	transport	mechanism	via	its	GTPase	cycle	between	GTP	and	
GDP-bound	 states	 (Fig.	 1-5).	 Relative	 to	 either	 state,	 Ran	 can	 differentially	 bind	 to	
specific	proteins	and	consequently	regulate	the	directionality	of	flow	of	molecules	across	
the	NPC	92.	In	the	import	pathway,	a	specific	importin	binds	to	its	designated	cargo	and	
facilitates	 its	 transport	 across	 the	 NPC.	 Once	 in	 the	 nucleus,	 RanGTP	 binds	 to	 the	
importin-cargo	 complex,	 mediates	 the	 release	 of	 the	 cargo	 and	 travels	 back	 to	 the	
cytoplasm	 associated	 with	 the	 importin	 receptor	 94.	 In	 the	 export	 pathway,	 instead,	
exportin	binds	to	both	the	cargo	and	RanGTP	and	all	three	in	a	complex	pass	through	the	
NPC	 toward	 the	 cytoplasm	 95.	 At	 the	 cytoplasmic	 face	 of	 the	 NPC,	 Nup358/RanBP2	
contributes	 in	 the	terminal	step	of	 the	export	of	 importin	or	exportin	receptors	 to	the	
cytoplasm.	 RanBP2	 binds	 to	 RanGTP	 through	 the	 RBD	 and	 activates	 Ran	 GTPase-
activating	 protein	 (RanGAP1)	 that	 indeed	 triggers	 GTP	 hydrolysis	 and	 subsequent	
disassembly	of	the	complexes	86,88,93,96,97.	Noteworthy	that	Nup358	is	not	only	capable	of	
binding	 Ran	 protein	 but,	 as	 it	 has	 been	 reported	 previously,	 Nup358	 protein	 harbors	
docking	sites	 for	binding	 the	heterodimeric	mRNA	export	 receptor,	NXF1-p15,	and	 the	
export	factor,	exportin-1	98,99.	
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Figure	 1-5	 |	 The	Ran-GTPase	 cycle	 during	 the	 import/export	 pathways.	During	 the	 import	 cycle	 (left),	
importin	binds	to	its	cargo	in	the	cytoplasm	then	is	transported	into	the	nucleus	through	the	NPC.	In	the	
nucleus,	RanGTP	binds	to	 importin	and	the	cargo	 is	released.	The	 importin/RanGTP	is	then	recycled	 into	
the	cytoplasm,	where	RanGTP	dissociates	from	the	importin,	and	GTP	is	hydrolyzed	into	GDP	by	the	action	
of	 the	Ran-GTPase.	While	 in	 the	export	 cycle	 (right),	RanGTP	binding	 to	exportin	 in	 the	nucleus	 induces	
binding	to	the	cargo	and	its	transport	through	the	NPC	to	the	cytoplasm,	where	GTP	hydrolysis	takes	place	
and	thus	the	cargo	is	free	in	the	cytoplasm	and	the	exportin	is	recycled	back	to	the	nucleus	100.	In	either	
pathway,	 the	GTP	 hydrolysis	 is	 induced	 by	 RanBP2	 binding	 to	 RanGTP,	 following	which	 RanGTPase	 1	 is	
activated.	
1.4.3. Implications	in	pathophysiology	
In	humans,	a	few	missense	mutations	in	RanBP2	gene,	specifically	in	the	leucine-
rich	 region,	 have	 been	 linked	 to	 the	 susceptibility	 of	 familial	 and	 recurrent	 acute	
necrotizing	 encephalopathy	 (ANE)	 101.	 ANE	 is	 a	 rapid	 and	 progressive	 encephalopathy	
that	occurs	to	previously	healthy	children	following	their	encounter	of	viral	infections	as	
mycoplasma,	influenza	and	herpes	simplex	virus.	Though	there	is	no	strong	link	between	
Nup358	malfunction	and	a	specific	syndrome	or	disease,	several	studies	were	performed	
on	 mouse	 models	 to	 identify	 the	 involvement	 of	 Nup358	 in	 pathophysiology.	
Nup358/RanBP2-/-	 mice	 are	 embryonic	 lethal,	 while	 the	 haploinsufficiency	 of	 RanBP2	
causes	the	levels	of	the	enzyme	hexokinase-1	(HKI)	and	ATP	to	drop	down	selectively	in	
the	central	nervous	system.	Whereas	non-neuronal	cells	maintain	normal	 levels	of	HKI	
and	ATP;	this	suggests	a	 link	between	Nup358	and	neuronal	metabolism	102.	Further,	a	
recent	 study	 showed	 that	 conditional	 ablation	 of	 Nup358	 in	 mouse	 motoneurons	
resulted	 in	 various	 traits	 that	 resembled	 ALS-like	 syndrome	 such	 as	 hypoactivity,	
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hindlimb	 paralysis,	 and	 decreased	 nerve	 conduction	 velocity.	 These	 defects	 were	
primarily	related	to	disruptions	in	the	nucleocytoplasmic	partitioning	of	importin-β	and	
exportin-1	and	in	chemokine	and	metalloproteinase	signaling	103.		
Alternative	studies	done	on	mammalian	cell	lines	demonstrated	that	Nup358	loss	
has	no	significant	consequence	on	protein	import	into	the	nucleus	but	slightly	affects	the	
export	of	mRNA	and	signal-bearing	proteins	81.	In	neuronal	cell	lines,	Nup358	was	shown	
to	 be	 a	 substrate	 for	 Parkin,	 one	 causative	 agent	 of	 autosomal	 recessive	 juvenile	
parkinsonism	(AR-JP).	Upon	binding	to	Parkin,	Nup358	is	ubiquitinated	and	degraded	via	
the	 proteasome	 pathway,	 thus	 implying	 Nup358	 involvement	 in	 the	 pathogenesis	 of	
Parkinson’s	disease	104.	Moreover,	a	recent	report	indicates	that	Nup358	binds	through	
its	RBD3	to	ubiquitin	and	regulates	its	levels	in	neurons	in	an	age-dependent	manner	105.	
1.4.4. Nup358	role	beyond	the	NPC	
Due	 to	 its	 multi-domain	 configuration,	 Nup358	 role	 is	 not	 only	 limited	 to	
facilitating	nucleocytoplasmic	transport	but,	Nup358	has	a	more	pleiotropic	function	in	
the	regulation	of	several	cellular	activities.	
• In	non-neuronal	cells	
Cell	 division	 in	 eukaryotic	 cells	 includes	 several	 distinct	 steps,	 where	 NPCs	
disassembly	and	assembly	cycle	is	fundamental	in	such	ordered	process.	Early	following	
the	nuclear	envelope	breakdown,	NPCs	disassemble	 in	a	synchronous	yet	fast	manner.	
Fragments	 of	 the	NE	 and	 the	 transmembrane	 nucleoporins	 retract	 to	 the	 ER	whereas	
soluble	nucleoporins	disperse	in	the	cytoplasm	as	stable	subcomplexes	44.	Some	of	these	
nucleoporins	 take	 part	 in	 the	 mitotic	 spindle	 apparatus	 comprising	 the	 kinetochores,	
centrosome	 and	 spindles	 44,106.	 Nup358,	 associated	 with	 RanGAP1,	 relocates	 to	
microtubules	 (MTs)	 and	 mediates	 their	 stability.	 By	 attachment	 to	 MTs,	 Nup358	
modulates	microtubule–kinetochore	interactions	and	regulates	the	association	of	other	
components	 with	 the	 kinetochores	 107,108.	 Additionally,	 Nup358	 role	 extends	 to	 later	
phases	 in	 the	 mitotic	 process.	 After	 chromosomes	 are	 correctly	 positioned	 on	
microtubules	and	prior	to	anaphase,	Nup358	sumoylates	Topoisomerase	IIα	enzyme	that	
in	turn	acts	on	decatenation	of	sister	chromatids	off	the	centromeres	109.	Thus,	Nup358	
involvement	 is	 crucial	 throughout	 the	mitotic	 process,	 without	 which	 the	 cells	 would	
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enter	 into	 mitotic	 arrest	 at	 the	 G2/M	 phase,	 experience	 abnormal	 chromosome	
segregation,	metaphase	catastrophe,	and	formation	of	anaphase	bridges	109,110.		
Moreover,	 during	 the	 interphase	 period	 of	mammalian	 cell	 lines,	 Nup358	 was	
found	 to	 be	 associated	 as	 well	 with	 microtubules.	 While	 the	 bulk	 of	 Nup358	 is	
incorporated	 with	 NPCs	 at	 the	 nuclear	 rim,	 a	 fraction	 of	 the	 total	 pool	 of	 Nup358	
localizes	 in	 the	 cytoplasm	 at	 the	 tips	 of	 cell	 extensions.	 This	 cytoplasmic	 fraction	 of	
Nup358	binds	to	and	promotes	the	stability	interphase	microtubules	111.		
Besides	that,	a	few	studies	have	shown	that	Nup358	is	involved	in	the	regulation	
of	mRNA	translation	through	different	mechanisms.	On	the	one	hand,	Nup358	interacts	
with	 specific	mRNAs	 encoding	 secretory	 proteins	 and	 potentiates	 their	 translation	 112.	
And	on	the	other	hand,	Nup358	contributes	in	translational	repression	of	target	mRNA	
through	 binding	 to	 RNA	 and	 protein	 components	 of	 the	 miRNA-induced	 silencing	
complex	(miRISC)	113.	
• In	neurons		
A	 former	 study	 led	by	Paulo	Ferreira	aimed	 to	examine	whether	Nup358	has	a	
ubiquitous	or	a	cell	(tissue)-specific	expression	profile.	Nup358	gene	expression	analysis	
was	 conducted	 on	 various	 tissues	 including	 the	 liver,	 spleen,	 lungs,	 kidneys,	 skeletal	
muscle,	 retina,	heart	and	brain;	whereby	Nup358	was	 found	 to	be	highly	expressed	 in	
the	 retinal	 tissue	 114.	 Relative	 to	 differences	 among	 cell	 subtypes	 of	 the	 neuroretina,	
photoreceptors	 and	 some	 ganglion	 cells	 exhibit	 a	 relatively	 high	 expression	 level	 of	
Nup358	 and	 a	 distinctive	 distribution	 pattern	 115.	 In	 these	 cells,	 Nup358	 is	 not	 only	
present	associated	with	the	NPC,	but	also	in	the	cytoplasm	in	the	form	of	discrete	spots	
spatially	located	away	from	the	nuclear	rim.		Distinct	domains	of	Nup358	were	found	to	
interact	selectively	with	retina-specific	proteins	and	consequently	influence	the	neuronal	
function.	The	RBD4	and	CY	domains	of	Nup358	act	as	selective	chaperones	for	red/green	
opsins	 in	 cone	 photoreceptors	 116,117.	 Another	 functional	 motif	 of	 Nup358,	 located	
between	 RBD2	&	 RBD3,	 associates	with	 the	 neuronal	 KIF5C	 and	 the	 ubiquitous	 KIF5B	
microtubule-dependent	 motor	 proteins	 in	 a	 subpopulation	 of	 neuronal	 cells	
118,119.		Additionally,	the	CY	domain	can	associate	with	certain	subunits	of	the	19S	cap	of	
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the	 26S	 proteasome	 pathway	 120,	 	therefore	 suggesting	 that	 Nup358	 might	 be	 a	 key	
element	for	integrating	the	proteasome	pathway	with	protein	biogenesis	120.		
Further,	 Nup358	 localizes	 in	 the	 mitochondria-rich	 ellipsoid	 compartment	 of	
cone	 and	 rod	 photoreceptors	 115,	 and	 particularly	 associates	 through	 its	 LRR	with	 the	
mitochondrial	 metallochaperone	 Cox11,	 and	 the	 central	 enzyme	 in	 glycolysis,	 HKI	 102.	
This	distribution	pattern	of	Nup358	can	be	observed	 in	different	regions	of	the	central	
nervous	system	(CNS)	102.	In	the	same	neuronal	context,	Nup358	interacts	through	its	N-
terminus	 with	 members	 of	 the	 Par	 polarity	 complex,	 such	 as	 Dishevelled	 (Dvl)	 and	
atypical	protein	kinase	 (aPKC),	 to	modulate	neuronal	polarity	and	axon	specification	 in	
cultured	hippocampal	neurons	 121.	All	 in	all,	 the	multi-functional	 role	of	Nup358	varies	
according	 to	 its	 interaction	 with	 partner	 proteins	 in	 a	 cell-type	 dependent	 fashion.	
Considering	 the	previously	mentioned	studies,	Nup358	might	be	specifically	correlated	
with	the	overall	activity	of	neurons	and	possibly	be	implicated	in	neurological	diseases.	
1.5. The	in	vitro	development	of	neurons	
Neurons	 are	 amazingly	 polarized	 cells	 with	 two	 distinct	 compartments:	 the	
somatodendritic	and	axonal	compartments.	These	two	domains	differ	 in	not	only	their	
morphological	 characteristics	 but	 also	 in	 their	 molecular	 composition	 and	 function.	
Based	 on	 dendritic/axonal	 polarity,	 neurons	 can	 receive,	 integrate	 and	 transmit	 an	
electrochemical	 signal	 throughout	 the	 nervous	 system;	 thus,	 maintaining	 polarity	 is	
essential	 for	 proper	 neuronal	 function.	 Over	 the	 past	 decades,	 cultured	 hippocampal	
pyramidal	 neurons	 have	 been	 used	 as	 a	 model	 system	 to	 study	 the	 stages	 of	 axon-
dendrite	 differentiation	 during	 the	 in	 vitro	 neuronal	 development	 122.	 To	 obtain	 their	
characteristic	 morphology,	 cultured	 neurons	 pass	 through	 five	 main	 stages	 (Fig.	 1-6).	
Early	after	plating,	i.e.	during	the	first	24	hr	in	culture,	neurons	undergo	a	fundamental	
transition	in	their	shape	exhibited	by	the	rapid	outgrowth	of	one	neurite	over	the	rest.	
This	neurite	differentiates	to	become	the	axon	whereas	the	remaining	neurites	develop	
into	the	dendrites.	Based	on	this	model	of	 in	vitro	cultured	neurons,	axon	specification	
represents	the	initial	and	central	event	that	breaks	the	symmetry	and	gives	the	neuron	
its	typical	polarized	morphology.		
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Figure	 1-6	 |Sequential	 events	 of	 establishing	 neuronal	 polarity	 in	 cultured	 hippocampal	 neurons.	 A	
schematic	drawing	of	cultured	hippocampal	neurons	showing	the	five	main	stages	during	which	neurons	
acquire	their	characteristic	morphology.	Shortly	after	plating,	neurons	appear	round	with	few	protrusions	
(Stage	1).	These	minor	processes,	actively	extending	and	retracting,	develop	into	immature	neurites	of	an	
almost	identical	length	(Stage	2).	Of	these	neurites,	one	starts	to	grow	at	a	higher	rate	and	transforms	into	
the	 axon	 thus	 breaking	 the	 symmetry	 of	 neuronal	 cells	 (Stage	 3).	 The	 axon	 continues	 to	 grow	 in	 the	
following	 days	 and	 the	 remaining	 neurites	 differentiate	 into	 dendrites,	 which	 are	 relatively	 shorter	
processes	 with	 tapering	 ends	 (Stage	 4).	 The	 final	 stage	 involves	 dendritic	 arborization,	 formation	 of	
synaptic	contacts	and	establishment	of	the	neuronal	network	(Stage	5)	124.			
1.6. The	Axon	Initial	Segment		
Though	changes	in	morphology	might	be	easy	to	monitor,	the	establishment	and	
maintenance	 of	 neuronal	 polarity	 require	 a	 complex	 yet	 concerted	 involvement	 of	
intracellular/extracellular	mechanisms	and	cytoskeletal	dynamics	123.	In	the	first	days	in	
culture	and	after	axon	specification,	a	unique	highly-specialized	region	called	the	Axon	
Initial	Segment	(AIS)	is	identified	within	the	first	50-μm	of	the	proximal	part	of	the	axon	
in	most	neurons.	 The	AIS	 is	 formed	during	 the	 transition	 from	stage	3-4	 (see	Fig.	 1-6)	
which	is	around	three	to	four	days	of	the	in	vitro	development	of	hippocampal	neurons	
125.	Besides	its	role	in	maintaining	neuronal	polarity,	the	AIS	has	a	diffusion	barrier	and	
intracellular	 sorting	 system	 that	 selectively	 restrict	 the	 trafficking	of	proteins	 to	either	
the	 axonal	 or	 somatodendritic	 domains	 126.	 Thus,	 the	 AIS	 represents	 a	 physical	 and	
physiological	 barrier	 between	 the	 somatodendritic	 and	 axonal	 domains	
127,128.	 	Interestingly,	 the	AIS	 is	 the	 site	 responsible	 for	 the	generation	action	potential	
(AP)	due	to	the	high	density	of	ion	channels	present	at	this	specific	domain	of	a	neuron	
129.	 The	 protein	 composition	 of	 the	 AIS	 includes,	 as	 well,	 a	 few	 extracellular	 matrix	
molecules,	 cell-adhesion	 molecules,	 and	 cytoskeletal	 scaffold	 proteins	 (Fig.	 1-7).	 Of	
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these	 proteins,	 a	 giant	 protein,	 known	 as	 Ankyrin-G	 (AnkG),	 acts	 as	 the	 master	 AIS	
scaffold	that	orchestrates	the	assembly	and	the	clustering	of	other	AIS	proteins	127.		
	
	
	
	
Figure	1-7	|	The	Axon	Initial	Segment	Protein	Composition.	A	schematic	drawing	of	the	AIS	architecture.	
The	AIS	of	neurons	is	composed	of	a	high	density	of	the	ion	channels,	Nav	and	Kv,	that	are	shown	bound	to	
Ankyrin-G.	AnkG	binds	α2	and	b4-spectrin	and	associates	with	microtubules	via	EB1/EB3	and	Ndel1,	in	the	
sub-membranous	area.	Actin	is	shown	as	periodic	rings	along	the	AIS	130.	
While	 the	 protein	 composition	 of	 the	 AIS	 has	 already	 been	 characterized,	 the	
mechanisms	 that	 control	 the	 targeting	 of	 AIS	 proteins	 to	 their	 ultimate	 destination	
remain	poorly	understood.	Nonetheless,	as	neuronal	plasticity	has	been	a	hot	topic	for	
investigation,	AIS	 plasticity	 has	 also	been	 reported	 recently.	 A	 few	 studies	 in	 the	 field	
have	shown	that	the	AIS	architecture	can	be	modulated	by	the	developmental	stage	of	
the	neuron	or	by	altered	neuronal	activity.	For	 instance,	an	increased	neuronal	activity	
would	allow	calcium	 influx	 through	NMDA	or	P2X	 receptors	consequently,	Nav	and	Kv	
channels	 are	 endocytosed	 from	 the	 AIS	 plasma	membrane	 130.	 Moreover,	 changes	 in	
neuronal	activity	could	also	modulate	the	morphology	of	 the	AIS;	an	 increased	activity	
results	 in	 a	 shift	 of	 the	AIS	 toward	 the	distal	 region	of	 the	axon	whereas	 a	decreased	
activity	is	often	linked	to	an	increased	length	of	the	AIS	130.	
Indeed,	the	AIS	is	a	compartment	essential	for	neuronal	excitability	and	polarity.	
Though	a	great	deal	of	knowledge	is	achieved	about	its	role	and	protein	composition	yet	
the	AIS	modulation	and	correlation	with	neurological	diseases	are	not	fully	elucidated.		
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2. AIM	OF	MY	PHD	PROJECT	
Nuclear	 pore	 complexes	 are	multiprotein	 complexes	 embedded	 in	 the	 nuclear	
envelope	 of	 eukaryotic	 cells	 and	 best	 known	 for	 their	 central	 role	 in	 mediating	
nucleocytoplasmic	trafficking.		However,	this	view	of	NPCs	static	nature	and	function	has	
evolved	over	the	past	decade.	NPCs,	or	more	accurately	its	constituting	proteins	have	a	
rather	dynamic	characteristic	that	renders	them	capable	of	dissociating	off	the	NPC	and	
taking	part	in	the	regulation	of	cellular	activities	in	a	cell	type-specific	fashion.		
Nup358	is	one	constituent	of	the	NPC	that	has	a	dynamic	characteristic	in	a	cell-
type	dependent	manner.	Based	on	previous	studies,	Nup358	was	found	to	be	involved	in	
axon	 specification	 by	 interacting	 with	 the	 Par	 polarity	 complex;	 without	 Nup358,	
cultured	 neurons	would	 develop	multiple	 axons	 instead	 of	 an	 only	 one	 axon.	 Besides	
that,	 the	 multi-domain	 configuration	 of	 Nup358	 promotes	 selective	 interaction	 with	
specific	 proteins	 in	 certain	 subtypes	 of	 the	 neuron;	 consequently,	 Nup358	 acts	 as	 a	
chaperone	for	these	proteins	to	reach	their	destination	in	the	neuronal	cell.		
To	this	end,	I	assume	that	Nup358	might	have	a	central	role	in	the	establishment	
or	the	maintenance	of	polarity	in	cultured	neurons.		
To	address	this	topic,	I	outlined	three	broad	objectives:	
- Investigate	the	subcellular	distribution	pattern	and	protein	expression	of	
Nup358	
- Examine	changes	in	Nup358	behavior	during	the	in	vitro	development	of	
neurons		
- Test	the	effect	of	various	pharmacological	treatments	on	Nup358	profile	
and	 expression	 to	 investigate	 possible	 correlation	 between	 Nup358	
behavior	and	neuronal	activity 
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3. RESULTS	
3.1. Nup358	distribution	pattern	in	mature	cultured	neurons		
Apart	 from	 its	 classical	 association	 with	 NPCs	 and	 involvement	 in	 the	
nucleocytoplasmic	 transport,	 previous	 reports	 have	 shown	 that	 Nup358	 is	 capable	 of	
binding	 and	 modulating	 the	 stability	 of	 microtubules	 in	 mammalian	 cell	 lines	
107,111.	 	Microtubules	 (MTs),	 in	 neuronal	 cells,	 have	 a	 central	 role	 in	 numerous	 cellular	
and	 developmental	 processes	 including	 neuronal	 polarity,	 differentiation	 and	
intracellular	 trafficking	 133.	 Thus,	 I	 aimed	 to	 analyze	 the	 subcellular	 localization	 of	
Nup358	relative	to	MTs	as	a	first	step	toward	characterizing	Nup358	protein	in	cultured	
neurons.	14	days	in	vitro	(DIV)	mouse	cortical	neurons	were	immunostained	for	Nup358	
and	 bIII-tubulin,	 a	 neuron-specific	 marker	 for	 microtubules.	 As	 expected,	 Nup358	
decorated	the	boundaries	of	cell	nuclei	due	to	 its	association	with	NPCs	at	the	nuclear	
envelope	(Fig.	3-1,	A).	However,	Nup358	was	expressed	as	well	in	the	cell	soma	and	the	
neuronal	 network,	 and	 remarkably	 enriched	 in	 specific	 processes	 originating	 from	
individual	 neuronal	 cells	 (Fig.	 3-1,	 A;	 Arrowheads).	 To	 identify	 the	 nature	 of	 these	
processes,	whether	dendritic	or	axonal,	cultured	neurons	were	 immunostained	 for	 the	
dendritic	marker	MAP2.	 Consequently,	 Nup358	was	 shown	 clustered	 in	 the	 processes	
where	MAP2	 signal	 was	 excluded	 (Fig.3-1,	 B),	 thus	 suggesting	 that	 Nup358	 localizes,	
preferentially,	 in	 the	axon	or	more	 specifically	 in	 the	axon	 initial	 segment	 (AIS)	 as	 the	
high-intensity	 signal	 of	 Nup358	 was	 restricted	 to	 the	 first	 part	 of	 the	 MAP2-free	
processes.	Indeed,	co-immunostaining	for	the	AIS	marker,	Ankyrin-G	(AnkG),	showed	an	
almost	perfect	overlapping	with	Nup358	fluorescence	signal	at	the	AIS	(Fig.	3-1,	C).	
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Figure	 3-1	 |	 Nup358	 clusters	 at	 the	 axon	 initial	 segment	 of	 mature	 cortical	 neurons.	 14	 DIV	 mouse	
cortical	neurons	were	co-immunostained	for	Nup358	(green)	and:	(A)	bIII-tubulin,	a	microtubule	marker,	
(B)	 MAP2,	 microtubule-associated	 protein	 2	 present	 exclusively	 in	 dendrites,	 and	 (C)	 AnkG,	 a	 scaffold	
protein	present	in	high	density	at	the	axon	initial	segment	(red).	Arrowheads	mark	the	high	fluorescence	
intensity	of	Nup358	in	specific	regions	of	the	neuronal	network	identified	by	the	lack	of	MAP2	signal	in	(B)	
or	by	the	overlapping	with	AnkG	staining	in	(C).	(Scale	bar:	10µm).	
Because	one	fraction	of	the	total	pool	of	Nup358	had	a	spotted	pattern	in	the	cell	
body	of	neurons,	 I	assessed	whether	 these	Nup358	puncta	 lie	within	any	of	 the	major	
subcellular	 compartments	 and	 organelles:	 the	 endoplasmic	 reticulum	 (ER),	 the	 Golgi	
apparatus	and	the	mitochondria.	Accordingly,	cortical	neurons	were	co-immunostained	
for	the	following	markers:	Calnexin	for	detecting	the	ER	(Fig.	3-2,	A),	p58	as	a	cis-Golgi	
marker	(Fig.	3-2,	B),	and	COX1	as	a	marker	for	mitochondria	(Fig.	3-2,	C).	In	contrast	to	
some	 previous	 studies	where	 Nup358	was	 identified	 in	 the	mitochondria	 of	 neuronal	
cells	102,115,	our	cultures	of	mouse	cortical	neurons	show	Nup358	discrete	puncta	mainly	
present	 in	 the	 ER	 whereas	 in	 juxtaposition	 with	 the	 Golgi	 and	 absent	 from	 the	
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mitochondria.	Such	differences	in	the	subcellular	distribution	of	Nup358	could,	however,	
be	influenced	by	differences	among	cell	types.		
	
Figure	 3-2	 |	 Nup358	 somatodendritic	 puncta	 co-localize	 with	 the	 endoplasmic	 reticulum.	
Immunostaining	 of	 mature	 14	 DIV	 cortical	 neurons	 for	 Nup358	 and	 markers	 of	 the	 main	 cellular	
organelles:	 (A)	Calnexin	as	a	marker	for	the	endoplasmic	reticulum,	(B)	p58	for	the	Golgi	apparatus,	and	
(C)	 cytochrome	c	oxidase	 I	 (COX1)	 for	 the	mitochondria.	Note	 that	Nup358	punctate	pattern	 in	 the	 cell	
soma	overlaps	 only	with	 the	 endoplasmic	 reticulum	 staining,	 as	 depicted	 in	 the	magnified	 views	of	 the	
boxed	areas,	shown	on	the	right	of	the	overlay	images.	(Scale	bar:	10µm).  	
Taken	together,	these	results	demonstrate	that	Nup358	subcellular	localization	is	
not	restricted	by	its	association	with	NPCs	at	the	nuclear	envelope.	Instead,	Nup358	has	
a	more	dynamic	behavior,	present	in	a	punctate	pattern	in	the	cell	soma	and	neuronal	
processes,	and	clustered	at	the	AIS	of	mature	neurons.	As	the	AIS	is	a	unique	neuronal	
compartment,	 in	 both	 its	 physiological	 function	 and	 physical	 architecture,	 this	 finding	
underlies	 an	 unprecedented	 involvement	 for	 a	 nucleoporin,	 Nup358,	 in	 the	 overall	
function	of	neurons.  
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3.2. Among	nucleoporins,	Nup358	has	a	unique	behavior	in	neurons	
The	 intracellular	 expression	 of	 Nup358	 in	 areas	 other	 than	 the	 NE	 reflects	 its	
dynamic	behavior	in	neuronal	cells.	However,	a	few	other	nucleoporins	were	reported	to	
have	a	dynamic	behavior	as	well,	according	to	their	position	in	the	NPC	architecture	and	
their	functional	role	in	nucleocytoplasmic	trafficking	69.	Thus,	to	better	identify	whether	
nucleoporins	are	commonly	present	 in	the	cytoplasm	of	neuronal	cells	or	that	this	 is	a	
unique	feature	of	Nup358,	14	DIV	cortical	neurons	were	immunostained	using	Nup358	
antibody	and	a	generic	anti-nuclear	pore	complex	proteins,	antibody	m414	(Fig.	3-3,	A).	
In	 parallel,	 immunostaining	was	 conducted	 against	 Nup358	 and	 the	 following	 specific	
nucleoporins:	Nup153	of	the	nuclear	basket	structure	(Fig.	3-3,	B),	Nup98	that	resides	on	
both	the	nuclear	and	the	cytoplasmic	rings	of	the	NPC	(Fig.	3-3,	C),	and	most	importantly	
Nup88	that	associates	with	and	anchors	Nup358	at	the	cytoplasmic	filaments	of	the	NPC	
(Fig.	3-3,	D).	Apart	from	Nup358,	all	the	tested	nucleoporins	were	expressed	at	the	NE	
due	to	their	association	with	the	NPCs.	These	nucleoporins	exhibited	a	sharp	perinuclear	
staining	whereas	no	signal	was	detected	in	either	the	cell	soma	or	neuronal	processes.	
Nup358,	 alternatively,	 had	 a	 unique	 distribution	 pattern	 in	 neurons,	 that	 extends	
beyond	the	perinuclear	region	and	does	not	necessarily	depend	on	 its	 interaction	with	
the	nucleoporin	Nup88.		
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Figure	3-3	|	The	subcellular	distribution	of	Nup358	relative	to	other	nucleoporins	of	the	NPC.	(A)	Mature	
14	DIV	mouse	cortical	neurons	were	immunostained	using	an	antibody	against	Nup358	and	the	antibody	
m414	that	recognizes	multiple	nucleoporins	having	phenylalanine-glycine	repeats	(FG).	(B-D)	Alternatively,	
14	 DIV	 cortical	 neurons	 were	 co-immunostained	 for	 Nup358	 and:	 (B)	 Nup153	 of	 the	 nuclear	 basket	
structure,	(C)	Nup98	present	at	both	faces	of	the	NPC,	or	(D)	Nup88	present	at	the	cytoplasmic	filaments	
of	 the	 NPC.	 Apart	 from	 Nup358,	 nucleoporins	 are	 preferentially	 expressed	 at	 the	 perinuclear	 region	
demonstrated	by	a	crisp	ring	around	cell	nuclei,	with	a	minimal	or	absent	signal	 in	the	cytoplasm.	(Scale	
bar:	10µm).		
Since	 the	 NPC	 mediates	 nucleocytoplasmic	 transport	 of	 molecules	 including	
RNAs,	 several	 nucleoporins	 such	 as	 Nup98	 and	 Nup153	 are	 known	 to	 interact	 with	
transcribed	RNAs	and	assist	their	export	to	the	cytoplasm.	In	this	context,	the	mobility	of	
these	 Nups	 on/off	 the	 NPC	 is	 transcription-dependent	 76.	 To	 investigate	 whether	 the	
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subcellular	 distribution	 of	 Nup35	 is	 influenced	 by	 RNA	 transcription,	 14	 DIV	 cortical	
neurons	were	treated	with	Actinomycin	D	(ActD;	5	μg/ml,	1	hr)	to	inhibit	transcription	by	
both	 RNA	 polymerases	 I	 and	 II.	 And	 to	 verify	 the	 efficiency	 of	 the	 ActD	 treatment,	
neurons	were	co-treated	with	5-EU,	a	Uracil	analog,	that	gets	incorporated	into	nascent	
RNAs	 during	 active	 transcription	 and	 can	 be	 detected	 with	 a	 click	 reaction	 using	 the	
fluorescent	dye,	5-FAM	(details	are	in	the	Materials	&	Methods	section).	While	control	
neurons	 showed	 5-EU	 labeling	 of	 newly	 synthesized	 RNAs	 in	 cell	 nuclei,	 ActD-treated	
neurons	had	no	detectable	signal	 for	an	active	transcription.	However,	with	respect	to	
Nup358	distribution	pattern,	no	 change	was	observed	 regardless	of	whether	 the	ActD	
treatment	 was	 included	 or	 not,	 thus	 ruling	 out	 the	 role	 of	 RNA	 transcription	 in	 the	
subcellular	distribution	profile	of	Nup358	(Fig.	3-4).	
	
Figure	3-4	|	Nup358	distribution	pattern	is	not	sensitive	to	the	inhibition	of	RNA	transcription.	Cultured	
neurons	were	treated	with	DMSO	as	control	(vehicle),	or	ActD	(5	μg/ml;	1	hr)	to	inhibit	RNA	polymerases	I	
and	II.	In	both	conditions,	neurons	were	simultaneously	incubated	with	5-EU,	an	artificial	analog	for	Uracil	
that	gets	 incorporated	 in	RNA	during	active	 transcription.	As	a	 result,	5-EU	was	present	 in	 the	nuclei	of	
control	 neurons	 whereas	 absent	 in	 ActD-treated	 cells.	 Immunostaining	 for	 Nup358	 showed	 similar	
distribution	patterns	of	Nup358	in	both	treated	and	untreated	neurons.	(Scale	bar:	10µm).	
3.3. Nup358	subcellular	distribution	changes	during	neuronal	development	 	
Although	Nup358	localization	in	the	ER	and,	generally,	its	spotted	pattern	in	the	
cell	body	and	neuronal	processes	were	worth	further	investigation,	these	findings	were	
beyond	 the	 scope	 of	 the	 present	 project.	 Instead,	 the	 focus	 was	 directed	 towards	
studying	Nup358	 localization	 at	 the	AIS.	 To	 this	 end,	Nup358	distribution	pattern	was	
examined	 in	 a	 time-dependent	 manner	 during	 the	 in	 vitro	 development	 of	 neurons,	
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including	 AIS	 maturation.	 Cultured	 mouse	 cortical	 neurons	 were	 fixed	 at	 different	
developmental	 stages	 (1-7,	 and	14	DIV)	and	co-immunostained	 for	Nup358	and	AnkG.	
Immunostaining	for	AnkG	was	chosen	for	two	main	reasons:	1)	AnkG	is	one	of	the	early	
markers	of	AIS	 formation	 127,	and	2)	AnkG	 is	crucial	 for	 the	concentration	of	other	AIS	
proteins	 including	 voltage-gated	 sodium	 and	 potassium	 channels	 134,135,	 and	 the	 cell	
adhesion	molecules	NrCAM	and	neurofascin-186	136.		
As	early	as	1	DIV,	Nup358	was	detected	in	the	cell	soma	of	cultured	neurons,	in	
the	 form	 of	 discrete	 spots	 (Fig.	 3-5,	 A;	 1	 DIV).	 This	 spotted	 pattern	 was	 enhanced	
progressively	 during	 an	 increased	 period	 in	 culture	 correlating	 with	 neuronal	
development.	At	 5	DIV,	when	AnkG	was	noticeably	 recruited	 at	 the	AIS	 of	 developing	
neurons,	Nup358	was	weakly	detected	at	this	specific	region	(Fig.	3-5,	A;	5	DIV).	A	few	
days	later	in	neuronal	development,	Nup358	was	evident	at	the	AIS	and	the	perinuclear	
region,	 along	 with	 its	 spotted	 pattern	 in	 the	 cell	 soma	 and	 the	 rest	 of	 the	 neuronal	
network	 (Fig.	 3-5,	 A;	 7	 DIV).	 Subsequently,	 in	 14	 DIV	 mature	 neurons,	 Nup358	 was	
significantly	 more	 clustered	 at	 the	 AIS	 (see	 Fig.	 3-1).	 At	 this	 stage	 of	 development,	
Nup358	distribution	pattern	was	consisting	of	three	identified	fractions	of	the	total	pool:	
one	fraction	was	localized	at	the	nuclear	rim,	associated	with	NPCs,	another	fraction	was	
present	 as	 discrete	 spots	 in	 the	 cell	 soma	 and	 processes,	 and	 a	 third	 fraction	 was	
enriched	at	the	AIS	along	with	AnkG	signal.	Collectively,	these	results	demonstrate	that	
the	 subcellular	 distribution	 of	 Nup358	 changes	 relatively	with	 neuronal	 development,	
and	 suggest	 that	 Nup358	 clustering	 at	 the	 AIS	 is	 dependent	 on	 AnkG	 precedent	
localization	in	this	region.	
At	the	protein	level,	the	temporal	expression	of	Nup358	protein	was	assessed	by	
immunoblotting	homogenates	of	cortical	neurons	cultured	for	different	time	intervals,	7	
to	 21	 DIV.	 In	 line	 with	 the	 immunocytochemistry	 analysis,	 the	 expression	 of	 Nup358	
protein	was	increasing	progressively	during	the	development	of	neurons.	This	increasing	
trend	was	observed	for	a	band	of	around	230	kDa	MW,	which	is	less	than	the	reported	
MW	 of	 the	 mouse	 Nup358	 protein,	 ∼341	 kDa,	 whose	 expression	 remained	 almost	
unchanged	over	the	tested	time	course	(Fig.	3-5,	B).	To	have	a	wider	frame	for	analysis	
during	 neuronal	 development,	 Nup358	 protein	 expression	 was	 examined	 in	 mouse	
cortices	obtained	at	different	ages:	at	the	embryonic	stage	E18	and	during	the	postnatal	
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period	 P0-P90.	 The	 result	 was	 comparatively	 similar	 to	 that	 obtained	 with	 cultured	
neurons,	 showing	 an	 increased	 expression	 of	 the	 shorter	 isoform	 and	 an	 opposite	
gradual	decrease	in	expression	of	the	full-length	Nup358	(Fig.	3-5,	C).	Next,	I	questioned	
whether	 the	 developmental	 changes	 in	 Nup358	 protein	 expression	 were	 somehow	
paralleled	 by	 changes	 in	 expression	 of	 other	 nucleoporins.	 Hence,	 protein	 samples	 of	
mouse	 cortices	 were	 immunoblotted	 for	 the	 following	 nucleoporins:	 Nup153,	 Nup98,	
and	 Nup88.	 Surprisingly,	 a	 decrease	was	 observed	 in	 expression	 of	 both	 Nup153	 and	
Nup98	 relatively	 as	 neurons	 develop,	 whereas	 expression	 of	 Nup88	 was	 almost	
unchanged	 (Fig.	 3-5,	 D).	 Therefore,	 both	 the	 immunocytochemistry	 and	 the	Western	
blotting	analyses	infer	a	development-dependent	change	in	not	only	Nup358	subcellular	
distribution	in	neurons	but	also	in	its	protein	expression	of	the	two	isoforms.	
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Figure	 3-5	 |	 Spatio-temporal	 expression	 of	 Nup358	 during	 neuronal	 development.	 (A)	Mouse	 cortical	
neurons	were	cultured	 for	different	DIV	before	being	 fixed	and	 immunostained	 for	Nup358	 (green)	and	
AnkG	(red).	At	5	DIV,	AnkG	expression	is	noticeable	at	the	AIS,	whereas	Nup358	had	a	spotted	pattern	in	
the	cell	soma.	At	7	DIV,	Nup358	is	detected	at	the	nuclear	rim	and	co-expressed	with	AnkG	at	the	AIS.	The	
arrowheads	point	 to	 the	recruitment	of	Nup358	and/or	AnkG	to	 the	AIS.	This	 is	better	demonstrated	 in	
the	magnified	view	of	 the	boxed	area	of	 the	overlay	 image	of	 the	7	DIV	neurons.	 (Scale	bar:	10µm).	 (B)	
Developmental	expression	of	Nup358	protein	in	cortical	neurons	(CNs)	cultured	for	different	days	in	vitro.	
Note:	the	high	MW	Nup358	was	weakly	detected	in	cultured	neurons	so	another	antibody	was	used,	that	
proved	 to	have	higher	 affinity	 for	 the	341	 kDa	band	of	Nup358.	 (C)	Homogenates	of	mouse	 cortices	of	
different	ages	were	immunoblotted	for	Nup358.	The	full-length	and	the	shorter	isoforms	of	Nup358	have	
opposite	trends	varying	gradually	during	neuronal	development.	The	arrows	point	to	the	two	isoforms	of	
Nup358.	(D)	Western	blot	of	mouse	cortices	showing	developmental	changes	in	the	expression	level	of	the	
nucleoporins:	 Nup153,	 Nup98,	 and	 Nup88.	 Both	 Nup153	 and	 Nup98	 decrease	 in	 expression	 during	
neuronal	development,	in	contrast,	no	change	was	observed	in	the	expression	of	Nup88. 
3.4. Neurons	express	two	isoforms	of	Nup358	
Apart	from	a	predicted	80	kDa	isoform	105,	no	other	isoform	has	been	previously	
reported	 for	 Nup358.	 Thus,	 I	 aimed	 to	 verify	 the	 identity	 of	 the	 230	 kDa	 band	 as	 a	
shorter	Nup358	using	mass	spectrometry	 (MS).	Nup358	was	 immunoprecipitated	 from	
P30	mouse	cortex	and	the	sample	was	loaded	on	an	SDS-PAGE	gel;	after	which	the	gel	
was	 incubated	with	Coomassie	 stain	 to	detect	 the	230	kDa	band	and	 finally	analyze	 it	
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using	MS	(Fig.	3-6,	A).	The	resulting	analysis	identified	40	unique	peptides	for	Nup358,	a	
number	 which	 is	 sufficient	 to	 confirm	 that	 the	 230	 kDa	 band	 belongs	 to	 Nup358.	
Interestingly,	a	 few	AIS	proteins,	 including	AnkG,	have	been	 identified	as	well	with	the	
shorter	isoform	of	Nup358	(Fig.	3-6,	B).	However,	no	information	was	inferred	from	the	
MS	data	 about	 the	differences	 in	protein	 sequence	of	 the	 two	 isoforms,	 and	how	 the	
shorter	 isoform	 is	 produced	 remains	 unclear.	 Though,	 it	 is	 tempting	 to	 speculate	 that	
there	 is	 a	 developmental	 switch	 in	 expression	 of	 the	 two	 isoforms	 of	 Nup358;	
consequently,	 the	 shorter	 Nup358	 is	 assumed	 to	 be	 enriched	 at	 the	 AIS	 of	 mature	
neurons.	To	better	identify	which	of	the	two	isoforms	of	Nup358	is	preferentially	located	
in	 the	 nuclear	 rim	 or	 in	 the	 cytoplasm,	 including	 the	 AIS,	 a	 nucleo-cytoplasmic	
fractionation	 was	 conducted	 from	 14	 DIV	 neuronal	 lysate	 according	 to	 a	 previous	
protocol	with	minor	modifications	 137.	 The	 efficiency	 of	 fractionation	was	 assessed	 by	
immunoblotting	with	the	nuclear	marker	Lamin	B1,	and	the	cytoplasmic	markers	GAPDH	
and	 b-tubulin.	 The	 results	 obtained	 supported	 the	 hypothesis	 that	 the	 full-length	
Nup358	is	enriched	in	the	nuclear	fraction,	conversely,	the	shorter	isoform	is	present	in	
the	cytoplasmic	fraction	(Fig.	3-6,	C).	Further,	since	Nup358	is	part	of	the	NPC	present	in	
the	nuclear	envelope,	Nup358	might	be	expressed	 in	virtually	all	eukaryotic	cell	 types.	
Therefore,	lysates	of	HeLa	and	NSC-34	cell	lines	along	with	21	DIV	neuronal	lysate	were	
immunoblotted	 for	 Nup358.	 In	 both	 cell	 lines,	 the	 expression	 of	 full-length	 isoform	
Nup358	 was	 prevalent	 whereas	 in	 cultured	 neurons,	 the	 shorter	 isoform	 was	
preferentially	expressed,	 thus,	 suggesting	 that	 the	 shorter	 isoform	 is	 a	neuron-specific	
isoform	of	Nup358	(Fig.	3-6,	D).	N.B.	Cultured	neurons	have	weak	expression	of	the	full-
length	isoform,	compared	to	cell	lines,	that	can	be	detected	using	another	anti-Nup358	
antibody	as	in	(Fig.	3-5,	B).	
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Figure	3-6	|	Differential	 expression	of	Nup358	 isoforms.	 (A)	 Immunoprecipitation	of	Nup358	 from	P30	
mouse	 cortex	 to	 detect	 the	 230	 kDa	 isoform	 of	 Nup358.	 (B)	 Table	 highlighting	 the	 results	 of	 mass	
spectrometry	 analysis	 (of	 probability	 over	 95%).	 Nup358/RanBP2	 was	 identified	 in	 the	
immunoprecipitated	sample	together	with	AnkG	and	Neurofascin	that	are	known	to	localize	at	the	AIS.	(C)	
Immunoblots	of	14	DIV	cortical	neurons	 total	 lysate	 (total),	 the	cytoplasm-enriched	 fraction	 (Cyto.),	and	
the	 nuclear	 fraction	 (Nuc.).	 In	 the	 total	 lysate,	 both	 Nup358	 isoforms	 were	 detected.	 In	 the	 nuclear	
fraction,	 the	 high	 MW	 isoform	 of	 Nup358	 was	 detected,	 oppositely,	 the	 cytoplasmic	 fraction	 showed	
expression	of	the	lower	isoform.	Lamin	B1	was	used	as	a	nuclear	marker	whereas b-tubulin	and	GAPDH	
were	used	as	cytoplasmic	markers.	(D)	Lysates	of	HeLa	and	NSC-34	cell	 lines	and	21	DIV	cortical	neurons	
were	 immunoblotted	 for	Nup358.	 The	 arrows	 are	 used	 to	 point	 to	 the	 two	 isoforms	of	Nup358;	 bands	
marked	with	asterisks	are	probably	non-specific	bands.		
3.5. Nup358	expression	in	different	regions	of	the	CNS		
To	examine	the	expression	of	Nup358	protein	in	different	regions	of	the	Central	
Nervous	System	(CNS),	entire	brain,	hippocampus,	cortex,	and	spinal	cord	were	collected	
from	mice	 at	 a	 fixed	 age,	 i.e.	 P3,	 and	 processed	 for	Western	 blotting	 analysis.	 Equal	
amounts	 of	 protein	 samples	were	 loaded	on	 an	 SDS-PAGE	 gel	 and	 examined	 for	 their	
expression	of	Nup358	 isoforms.	Both	 isoforms	were	detected	 in	 all	 the	 tested	 tissues,	
with	 some	 variations	 in	 the	 expression	 level.	 In	 the	 brain,	 hippocampus,	 and	 cortex,	
expression	 of	 the	 full-length	 Nup358	 was	 higher	 than	 that	 of	 the	 shorter	 isoform	
whereas	the	reverse	result	was	observed	in	the	spinal	cord	that	has	higher	expression	of	
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the	 shorter	 isoform	 (Fig.	 3-7,	 A).	 These	 variations	 in	 expression	 levels	 of	 Nup358	
isoforms	are	likely	attributable	to	physiological	differences	among	neuronal	tissues.		
Further,	since	the	two	isoforms	of	Nup358	are	ubiquitously	expressed	in	the	CNS,	
changes	 in	Nup358	expression	 levels	were	monitored	during	 the	development	of	both	
the	hippocampus	and	the	spinal	cord.	Similar	to	the	developing	cortex	(see	Fig.	3-5,	C),	
both	 the	 hippocampus	 and	 the	 spinal	 cord	 showed	 an	 increased	 expression	 of	 the	
shorter	isoform	of	Nup358	and	a	decreased	trend	in	the	full-length	isoform	(Fig.	3-7,	B).	
Moreover,	 14	 DIV	 hippocampal	 neurons	 exhibited	 a	 distribution	 pattern	 of	 Nup3558	
similar	 to	 that	 of	 cultured	 cortical	 neurons	 (see	 Fig.	 3-1),	 present	 localized	 in	 the	
perinuclear	region,	the	cell	soma	and	the	AIS	(Fig.	3-7,	C).	In	contrast,	glial	cells	such	as	
astrocytes	 had	 a	 relatively	 less	 fluorescence	 signal	 of	 Nup358	 compared	 to	 neuronal	
cells,	as	shown	by	the	punctate	pattern	in	the	cytoplasm	and	at	the	nuclear	rim	(Fig.	3-7,	
D).		
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Figure	 3-7	 |	 Nup358	 protein	 is	 ubiquitously	 expressed	 in	 the	 CNS.	 (A)	 Western	 blot	 of	 brain,	
hippocampus	 (HIPP),	 cortex	 (CTX),	 and	 spinal	 cord	 (SpC)	 obtained	 from	P3	mouse.	 The	 two	 isoforms	of	
Nup358	 are	 commonly	 expressed	 in	 all	 the	 tested	 samples	 of	 neuronal	 tissues.	 (B)	 Development-
dependent	 changes	 in	Nup358	protein	 expression	 in	hippocampi	or	 spinal	 cords	obtained	 from	mice	of	
different	ages.	Two	antibodies	were	used	for	the	detection	of	Nup358	isoforms	since	each	antibody	has	a	
higher	affinity	for	detecting	one	isoform.	β-tubulin	served	as	the	loading	control	(in	A	and	B).	The	arrows	
point	 toward	 the	 two	 isoforms	 of	 Nup358	 having	 varying	 trends	 in	 expression	 during	 neuronal	
development.	The	arrowhead	is	directed	toward	an	unidentified	band	observed	in	the	P14	mouse	spinal	
cord.	 (C	 and	 D)	 Immunofluorescent	 images	 of	 14	 DIV	 cultured	 hippocampal	 neuron	 and	 astrocytes	
immunolabeled	for	Nup358	and	βIII-tubulin	in	(C)	or	GFAP	(glial	fibrillary	acidic	protein)	in	(D)	as	a	marker	
for	 astrocytes.	 Hippocampal	 neurons	 express	 Nup358	 at	 the	 nuclear	 rim,	 the	 cell	 soma	 and	 the	 AIS	
 
 
 
 
30 
whereas	astrocytes	have	Nup358	at	the	nuclear	rim	and	in	the	entire	cytoplasm	as	scattered	spots.	(Scale	
bar:	10µm).	
3.6. The	N-terminal	region	is	essential	for	Nup358	clustering	at	the	AIS 	
As	 Nup358	was	 found	 clustered	 at	 the	 AIS	 of	mature	 neurons	 (see	 Fig.	 3-1),	 I	
aimed	 to	 identify	 the	 region	 in	 its	 amino	 acid	 sequence	 essential	 for	 this	 specific	
localization.	Neurons	were	 transfected	with	GFP-co-expressing	 constructs	 that	 encode	
for	 different	 fragments	 of	 Nup358	 protein.	 However,	 preliminary	 experiments	 were	
done	 in	HeLa	cell	 line	to	verify	 the	efficiency	of	 the	constructs	 that	encode	for:	 the	N-
terminus	 of	 Nup358	 (GFP-Nup358-N,	 1-900	 amino	 acid	 residues),	 the	 middle	 region	
(GFP-Nup358-M,	 901-2219	 residues)	 and	 the	 C-terminus	 (GFP-Nup358-C,	 2220-3224	
residues)	 (Fig.	 3-8,	 A).	 The	 GFP-Nup358-N	 construct	 was	 expressed	 as	 filamentous	
structures	 surrounding	 the	 cell	 nucleus	 (Fig.	 3-8,	 B;	 GFP-Nup358-N),	 presumably	
localizing	at	microtubules	as	previously	reported	111	while	the	endogenous	Nup358	was	
present	 in	 trace	 amounts	 at	 the	 perinuclear	 region	 and	 as	 scattered	 spots	 in	 the	 cell	
cytoplasm.	 As	 for	 the	 overexpression	 of	 the	middle	 and	 the	 C-terminal	 regions,	 both	
showed	 a	 diffuse	 pattern	 but	 in	 contrasting	 locations	 in	 the	 cell.	 GFP-Nup358-M	was	
preferentially	localized	inside	the	nucleus	whereas	the	GFP-Nup358-C	was	expressed	in	
the	entire	 cytoplasm	of	HeLa	 cells	 (Fig.	3-8,	B;	GFP-Nup358-M	and	GFP-Nup358-C).	 In	
addition,	transient	transfection	of	the	full-length	Nup358	(GFP-Nup358-FL,	1-3224)	was	
conducted	 as	well,	where	 results	 showed	 expression	 of	 the	 exogenous	 protein	 at	 the	
nuclear	 rim	 and	 the	 cytoplasm	 overlapping	 with	 fluorescence	 signal	 of	 endogenous	
Nup358	(Fig.	3-8,	B;	GFP-Nup358-FL).		
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Figure	 3-8	 |	 Transient	 expression	 of	Nup358	 in	HeLa	 cell	 line.	 (A)	 Schematic	 representation	 of	 human	
Nup358,	 composed	 of	 3,224	 amino	 acid	 residues,	 showing	 the	 different	 domains	 expressed	 by	 the	
constructs	used	in	this	study:	The	N-terminus	(1-900	residues;	blue),	the	Middle	region	(901-2219;	yellow),	
and	the	C-terminus	(2220-3224;	violet).	(B)	Immunofluorescent	images	of	HeLa	cells	transfected	with	GFP	
co-expressing	constructs	that	encode	for	different	regions	of	Nup358:	GFP-Nup358-N	(1-900	amino	acids),	
GFP-Nup358-M	(901-2219),	and	GFP-Nup358-C	(2220-3224).	Besides,	HeLa	cells	were	transfected	with	the	
construct	 GFP-Nup358-FL	 encoding	 for	 the	 entire	 human	 Nup358	 protein	 (1-3224	 amino	 acids).	
Transfected	 cells	 overexpress	 the	N-terminus	 of	Nup358	 as	 filamentous	 structures	 surrounding	 the	 cell	
nucleus.	 The	 middle	 region	 is	 expressed	 preferentially	 inside	 the	 nucleus	 whereas	 the	 C-terminus	 is	
detected	in	the	entire	cytoplasm	of	transfected	cells.	Finally,	exogenously	expressed	full-length	Nup358	is	
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found	 around	 the	 cell	 nuclei	 and	 in	 the	 cytoplasm	 as	 punctate	 pattern.	 This	 distribution	 profile	 quite	
overlaps	with	that	of	endogenous	Nup358	(red).	(Scale	bar:	10μm).	 
In	a	neuronal	context,	transfection	of	the	Nup358	overexpressing	constructs	was	
primarily	conducted	in	10	DIV	rat	cortical	neurons	for	around	16	hr,	followed	by	fixation	
and	 immunostaining	 for	 Nup358.	 The	 GFP-Nup358-N	was	 ectopically	 expressed	 along	
the	 microtubules	 cytoskeleton	 in	 all	 neuronal	 processes	 of	 the	 transfected	 neuron,	
indistinguishable	between	the	axon	and	dendrites	 (Fig.	3-9,	A).	As	 for	 the	endogenous	
Nup358,	expression	was	 limited	 to	 the	spotted	pattern	 in	 the	cell	 soma	without	being	
detected	 in	 the	 nuclear	 rim	 or	 the	 AIS	 region.	 This	 result	 is,	 in	 fact,	 similar	 to	 that	
obtained	in	HeLa	cell	line	(see	Fig.	3-8,	B;	GFP-Nup358-N).		
To	examine	a	more	 specific	 subcellular	profile	 for	GFP-tagged	Nup358,	 a	hippocampal	
culture,	which	is	a	well-studied	model	of	homogenous	population	of	pyramidal	neurons	
122,		was	used	instead	of	cortical	neurons.	13	DIV	hippocampal	neurons	were	transfected	
with	the	previously	mentioned	constructs,	and	maintained	in	culture	for	2	days	to	allow	
expression	 of	 the	 exogenous	 protein.	 Then,	 neuronal	 cells	 were	 fixed	 and	
immunostained	 for	 AnkG	 to	 better	 identify	 the	 AIS	 and	 detect	 accordingly	 the	 co-
localization	 with	 Nup358	 at	 this	 specific	 region.	 In	 contrast	 to	 cortical	 neurons,	
hippocampal	neurons	exhibited	a	more	distinct	profile.	GFP-Nup358-N	was	 localized	at	
the	nuclear	rim,	 in	the	cell	soma	and	the	AIS	 (Fig.	3-9,	B;	GFP-Nup358-N),	 in	a	pattern	
very	much	similar	to	that	of	endogenous	Nup358.	According	to	the	present	data,	the	N-
terminus	includes	the	amino	acid	sequence	essential	for	Nup358	recruitment	to	the	AIS	
of	mature	neurons.	Regarding	transfection	with	the	other	constructs,	expression	of	the	
GFP-Nup358-M	 construct	 was	 unsuccessful	 in	 neurons,	 while	 expression	 of	 the	 GFP-
Nup358-C	construct	 resulted	 in	a	diffuse	pattern	 in	 the	cytoplasm	of	 the	neuronal	cell	
(Fig.	3-9,	B;	GFP-Nup358-C).	
Since	Nup358	has	two	 isoforms	 in	neuronal	 lysates	 (see	Fig.	3-5,	B),	one	 is	 full-
length	and	the	other	is	shorter,	I	examined	the	distribution	pattern	of	GFP-Nup358-FL	in	
neurons.	13	DIV	hippocampal	neurons	were	transfected,	likewise,	with	the	GFP-Nup358-
FL	 construct	 and	 maintained	 afterward	 in	 culture	 for	 a	 2-day	 period	 then	 fixed	 and	
immunostained	for	AnkG.	Surprisingly,	expression	of	the	full-length	Nup358	resulted	in	
its	localization	solely	at	the	perinuclear	region	without	any	signal	at	the	AIS	(Fig.	3-9,	B;	
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GFP-Nup358-FL).	To	address	possible	relocation	of	exogenously	expressed	GFP-Nup358-
FL,	the	incubation	period	was	prolonged	to	4	days’	post	transfection,	yet	the	distribution	
profile	was	almost	the	same	as	in	a	shorter	incubation	period	(data	not	shown).		
The	difference	in	the	distribution	pattern	of	endogenous	Nup358	(or	exogenous	
GFP-Nup358-N)	and	exogenous	GFP-Nup358-FL	might	be	related	to	the	presence	of	the	
short	 isoform	of	Nup358	as	observed	 in	 the	Western	blots	 (see	Fig.	3-5,	B).	While	 the	
GFP-Nup358-FL	 construct	 includes	 the	 N-terminus	 region	 of	 Nup358	 as	 in	 the	 GFP-
Nup358-N	 construct,	 I	 assume	 that	 the	 short	 isoform	of	Nup358	 has	 a	more	 dynamic	
behavior	in	neurons	and	includes	the	N-terminus	region	sufficient	for	its	clustering	at	the	
AIS.	Indeed,	investigating	how	the	two	isoforms	of	Nup358	are	produced	will	be	valuable	
to	understand	their	dynamics	and	behavior	in	neurons.	
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Figure	3-9	 |	 Exogenous	expression	of	Nup358	 constructs	 in	 cultured	neurons.	 (A)	Rat	 cortical	 neurons	
were	transfected	with	the	GFP-Nup358-N	construct	at	10	DIV	for	around	16	hr,	followed	by	fixation	and	
immunostaining	 for	Nup358	 (red).	Nup358	was	expressed	as	 filamentous	 structures	 in	 the	processes	of	
the	transfected	neuron.	 (B)	13	DIV	rat	hippocampal	neurons	exogenously	expressing	distinct	domains	of	
Nup358	and	the	 full-length	protein	using	constructs	co-expressing	green	fluorescent	protein	 (GFP):	GFP-
Nup358-N,	 GFP-Nup358-C,	 and	 GFP-Nup358-FL.	 Neurons	 were	 transfected	 at	 13	 DIV	 with	 the	
corresponding	 construct,	 fixed	 after	 48	hr	 in	 culture	 and	 immunostained	 for	AnkG	 to	 identify	 the	Axon	
Initial	 Segment	 (AIS).	Cells	 transfected	with	GFP-Nup358-N	 show	expression	of	 the	N-terminal	 region	at	
the	nuclear	 rim	and	 the	AIS	whereas	 cell	 transfected	with	GFP-Nup358-C	 show	expression	 in	 the	entire	
cytoplasm.	Cells	expressing	GFP-Nup358-FL	display	a	fluorescence	signal	around	the	nucleus.	The	asterisk	
and	the	arrowhead,	 in	GFP-Nup358-N	 images,	are	used	to	mark	transfected	and	untransfected	neurons,	
respectively.	(Scale	bar:	10µm).	
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3.7. Activity-dependent	decrease	in	Nup358	protein	expression	
Since	Nup358	is	enriched	at	the	AIS	that	is	the	site	of	synaptic	input	integration	
and	 action	 potential	 generation,	 I	 aimed	 to	 study	 whether	 inhibiting	 or	 stimulating	
neuronal	 activity	would	 trigger	 changes	 in	 Nup358	 expression	 or	 distribution	 pattern.	
For	 this	 purpose,	 specific	 treatments	 were	 applied	 on	 14	 DIV	 cortical	 neurons,	 as	
neurons	 at	 this	 stage	 of	 development	 are	 fully	 mature	 and	 have	 already	 established	
functional	 synapses	 138.	 The	 selected	 treatments	 included	 Tetrodotoxin	 (TTX)	 to	 block	
voltage-gated	Na+	channels,	Bicuculline	 (BIC)	 to	block	 the	 inhibitory	 function	of	GABAA	
receptors	 thus	 indirectly	 stimulating	 neurons,	 4-Aminopyridine	 (4-AP)	 that	 blocks	
voltage-gated	 K+	 channels	 therefore	 prolonging	 the	 action	 potential	 duration,	 and	 in	
some	cases	neurons	were	co-treated	with	BIC	and	4-AP.	Inhibiting	neuronal	activity	with	
TTX	did	not	interfere	with	Nup358	subcellular	localization	as	compared	with	the	control	
neurons	(Fig.	3-10,	A).	The	same	result	was	observed	with	the	BIC	treatment;	however,	
when	neurons	were	 treated	with	4-AP,	 there	was	a	decrease	 in	 the	 intensity	 signal	of	
Nup358	 (Fig.	 3-10,	 B).	 This	 overall	 effect	 was	 more	 pronounced	 when	 neurons	 were	
treated	with	both	BIC	and	4-AP,	showing	a	reduction	in	Nup358	intensity	at	the	nuclear	
ring	and	the	cell	soma	due	to	the	synergistic	effect	of	this	combination	of	treatments.	
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Figure	3-10	|	Nup358	signal	 intensity	 is	reduced	following	neuronal	stimulation.	Drug	treatments	were	
conducted	overnight	on	14	DIV	cortical	neurons	to	either	inhibit	or	stimulate	neuronal	activity.	(A)	Cortical	
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neurons	were	treated	with	Tetrodotoxin	(TTX;	1μM)	to	inhibit	neuronal	firing.	(B)	Bicuculline	(BIC;	50μM)	
and/or	 4-Aminopyridine	 (4-AP;	 0.5mM)	 treatments	were	 conducted	 to	 stimulate	 neurons.	 As	 a	 control,	
neurons	 were	 treated	 with	 an	 equivalent	 amount	 of	 DMSO	 (vehicle).	 Immunostaining	 was	 done	 for	
Nup358	and	AnkG.	A	considerable	decrease	 in	Nup358	fluorescence	 intensity	 is	observed	when	neurons	
were	treated	with	4-AP	alone	or	in	combination	with	BIC.	(Scale	bar:	10µm).	
These	 observations	 were	 further	 confirmed	 by	 the	 quantitative	 analysis	 of	
Nup358	 total	 fluorescence	 intensity	 using	 Operetta	 high-content	 imaging	 system;	 by	
which	neuronal	cells	were	detected	with	DAPI,	which	stains	the	cell	nuclei,	accordingly,	
Nup358	fluorescence	intensity	was	measured	in	these	cells	(details	are	in	the	Materials	
&	Methods	section).	Additionally,	Nup358	fluorescence	signal	was	measured	at	the	level	
of	the	somatodendritic	compartment	(including	Nup358	signal	at	the	perinuclear	region)	
and	at	the	level	of	the	AIS	as	identified	by	the	overlapping	signal	of	AnkG.	A	significant	
reduction	was	observed	in	Nup358	total	fluorescence	intensity	following	the	treatment	
with	4-AP	alone	(≈15%)	or	in	combination	with	BIC	(≈30%)	(Fig.	3-11,	A).	This	result	was	
paralleled	by	a	reduction	in	Nup358	signal	at	the	somatodendritic	domain	(Fig.	3-11,	B),	
whereas	 at	 the	 level	 of	 the	 AIS,	 Nup358	 signal	 remained	 unchanged	 (Fig.	 3-11).	
Noteworthy	 that	AnkG	 fluorescence	 intensity	was	 not	 even	 changed	 compared	 to	 the	
control	 neurons	 (Fig.	 3-11,	 D).	 This	 perhaps	 implies	 a	 robust	 stability	 of	 Nup358	 (and	
AnkG)	 at	 the	 AIS	 region	 that	 is	 influenced	 by	 the	 complex	 AIS	 architecture	 and	 the	
interplay	 of	 various	 proteins	 in	 this	 highly-specialized	 region.	 Moreover,	 Western	
blotting	analysis	was	conducted	as	well	 (Fig.	3-11,	E)	 for	neuronal	 lysates	 treated	with	
BIC	and/or	4-AP.		Since	the	short	isoform	is	the	predominantly	expressed	isoform	in	14	
DIV	neurons,	the	analysis	was	done	relative	to	the	230	kDa	Band	of	Nup358.	Indeed,	the	
results	 partially	 mirrored	 the	 immunocytochemistry	 quantitative	 analysis	 showing	 a	
significant	decrease	 in	Nup358	protein	expression	upon	 treating	neurons	with	each	of	
Bicuculline,	 4-AP,	 or	 with	 both	 simultaneously.	 Overall,	 these	 data	 conclude	 that	
stimulation	 of	 neurons	 affects	 negatively	 Nup358	 protein	 expression	 and	 distribution,	
however,	Nup358	 intensity	at	the	AIS	remains	 intact	 irrespective	of	the	changes	 in	the	
total	pool	of	Nup358.		
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Figure	3-11	|	Quantitative	analysis	of	Nup358	fluorescence	intensity	following	inhibition/stimulation	of	
neuronal	 activity.	 14	 DIV	mouse	 cortical	 neurons	 were	 treated	 overnight	 with	 each	 of	 TTX,	 BIC,	 4-AP,	
BIC/4-AP	or	DMSO	(vehicle)	and	immunostained	for	Nup358	and	AnkG.	(A)	Measurements	of	Nup358	total	
fluorescence	 intensity	 (Nup358	 total	 Fl.	 Int.).	 (B)	 Nup358	 fluorescence	 intensity	 at	 the	 somatodendritic	
compartments	 (Nup358	 Fl.Int.	 at	 Soma	 +	 Dendrites).	 (C)	 and	 (D)	 measurements	 of	 Nup358	 and	 AnkG	
fluorescence	 intensity	at	the	AIS	of	cortical	neurons	(Nup358	or	AnkG	Fl.Int.	at	 the	AIS).	 In	 (A-D)	 images	
were	 acquired	 using	 Operetta	 high-content	 imaging	 system	 and	 afterward	 analyzed	 with	 Harmony	
Software;	 the	 fluorescence	 intensity	 levels	 were	 normalized	 to	 the	 levels	 of	 the	 vehicle.	 (E)	 Nup358	
immunoblot	 of	 neuronal	 lysates	 treated	 with	 BIC	 and/or	 4-AP	 along	 with	 the	 quantifications	 of	 band	
intensity	 relative	 to	b-tubulin	 as	 shown	 on	 the	 right	 of	 the	 blot.	 Bars	 indicate	means	 ±SD;	 n=	 300-500	
neurons	 from	 21	 different	 fields	 per	 experiment	 (the	 results	 presented	 are	 the	 mean	 values	 of	 three	
separate	experiments)	and	wherever	demonstrated,	(*)	or	(**)	represent	significant	values	of	p<0.05	and	
p<0.01,	respectively.	Statistical	analysis	was	done	using	one-way	ANOVA	followed	by	Tukey’s	test.	
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3.8. Neuronal	depolarization	with	KCl	reduces	Nup358	expression	through	
Calcium	influx	and	NMDARs	
As	 demonstrated,	 the	 increased	 neuronal	 activity	 alters	 Nup358	 subcellular	
distribution	and	dampens	its	protein	expression.	This	link	between	neuronal	activity	and	
Nup358	distribution/expression	was	further	studied	by	inducing	neuronal	depolarization	
with	 KCl,	 a	 commonly	 used	 treatment	 for	 stimulating	 neurons.	 Depending	 on	 the	
developmental	 stage,	 neurons	 convey	 KCl	 treatment	 into	 distinct	 signaling	 pathways	
that	 trigger	 local	 protein	 synthesis	 138,	 overall	 increase	 in	 histone	 acetylation,	 gene-
specific	 alternative	 splicing	 and	 increased	 chromatin	 accessibility	 139,	 dendritic	
arborization	140,141,	synaptogenesis	and	increased	synaptic	strength	142,143.		
To	examine	how	neuronal	depolarization	influences	Nup358	subcellular	distribution	and	
protein	expression,	14	DIV	neurons	were	treated	with	KCl	to	a	final	concentration	of	50	
mM.	Alternatively,	 neurons	were	 treated	with	 an	 equivalent	 concentration	 of	NaCl	 as	
controls	to	maintain	the	osmotic	concentration	of	monovalent	 ions.	Assessment	of	cell	
death	and	neuronal	integrity	was	done	by	staining	cell	nuclei	with	DAPI	and	the	dendritic	
processes	with	MAP2.	
Regarding	 Nup358	 subcellular	 distribution,	 KCl-treated	 neurons	 showed	 a	
significant	 change	 in	Nup358	profile	 noted	by	 the	 loss	of	 the	 sharp	 localization	 at	 the	
nuclear	 rim,	whereas	 at	 the	 level	 of	 the	AIS,	Nup358	 signal	was	 persistent	 relative	 to	
AnkG	 staining	 (Fig.	 3-12,	 A).	 In	 contrast,	 no	 change	was	 observed	 in	 the	NaCl-treated	
neurons.	The	 reduction	 in	Nup358	 fluorescence	 intensity	 following	 KCl	 treatment	was	
reflected	 in	 a	 decrease	 in	 its	 protein	 expression	 level,	 as	 shown	 by	 the	Western	 blot	
analysis	of	KCl-treated	neurons	versus	untreated	neurons	(Fig.	3-12,	B).	Theoretically,	a	
decrease	in	protein	expression	might	be	modulated	by	an	increased	proteasome	activity.	
To	 investigate	 such	 possibility,	 neurons	 were	 treated	 with	 MG132,	 a	 proteasome	
inhibitor,	prior	to	the	treatment	with	KCl.	Indeed,	immunoblotting	showed	that	MG132	
treatment	did	not	recover	Nup358	protein	level	following	the	treatment	with	KCl;	thus,	
ruling	out	the	role	of	proteasomes	in	the	KCl-mediated	decrease	in	Nup358	expression	
level	 (Fig.	 3-12,	 C).	 Alternatively,	 the	 decrease	 in	 Nup358	 protein	 might	 be	 a	
consequence	 of	 a	 substantial	 decrease	 in	 the	 mRNA	 level.	 To	 this	 end,	 qRT-PCR	 was	
conducted	 in	 KCl	 treated/untreated	 samples	 and	 Nup358	 mRNA	 was	 quantified	 and	
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normalized	on	GAPDH	 level	 (Fig.	3-12,	D).	Notably,	 the	 level	of	Nup358	 transcript	was	
significantly	 reduced	 in	 neurons	 treated	 with	 KCl,	 therefore,	 neuronal	 depolarization	
with	KCl	triggers	a	decrease	in	both	the	protein	and	the	mRNA	levels	of	Nup358.	
	
	
Figure	 3-12	 |	 KCl-mediated	 decrease	 in	 Nup358	 protein	 expression.	 (A)	 14	 DIV	 cortical	 neurons	 were	
treated	with	KCl	at	a	final	concentration	of	50mM,	and	as	control,	neurons	were	treated	instead	with	an	
equivalent	concentration	of	NaCl.	Immunostaining	was	done	for	Nup358	(green)	and	MAP2	(red)	to	assess	
the	 cytoskeletal	 integrity	 of	 neuronal	 processes	 which	 was	 not	 compromised	 following	 the	 treatment.	
(Scale	bar:	10µm).	(B)	Immunoblot	of	KCl-treated	neuron	lysates	showing	an	approximate	30%	reduction	
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in	Nup358	 protein	 level.	On	 the	 right	 is	 the	 quantification	 of	Nup358/Actin	 ratios	 in	 KCl-treated	 versus	
control	 neurons;	 where	 Actin	 served	 as	 the	 loading	 control.	 (C)	 14	 DIV	 neurons	 were	 pretreated	 with	
MG132	 (1μM;	 overnight)	 and	 then	 with	 KCl	 (50mM,	 1hr)	 to	 assess	 the	 role	 of	 proteasomes	 in	 KCl-
mediated	 effect.	 Alternatively,	 neurons	 were	 treated	 with	 KCl	 alone,	 or	 NaCl	 to	 serve	 as	 controls.	
Compared	 to	 the	 control,	 both	 KCl-	 and	 KCl+MG132-treated	 neurons	 show	 reduced	 levels	 of	 Nup358	
protein.	(D)	qPCR	analysis	showing	a	relative	decrease	in	Nup358	mRNA	level	in	KCl-treated	compared	to	
the	control	neurons;	normalization	was	performed	on	GAPDH	mRNA	level.	Bars	 indicate	means	±SD	and	
wherever	 demonstrated	 (*)	 or	 (**)	 represent	 significant	 values	 of	 p<0.05	 and	 p<0.01,	 respectively.	
Statistical	analysis	was	done	using	two-tailed	Student’s	t-test.	
To	 further	 investigate	 the	 KCl-underlying	 mechanism,	 certain	 drug	 treatments	
were	applied	on	neurons	 to	examine	 the	 rescue	of	Nup358	protein	expression	and/or	
distribution	pattern.	Thus,	neurons	were	pretreated	with:	EGTA	to	block	calcium	entry,	
APV	 to	 block	 NMDA	 receptors,	 or	 CNQX	 that	 is	 an	 AMPA	 receptor	 antagonist.	 These	
treatments	were	selected	since	membrane	depolarization	and	the	subsequent	increase	
in	 calcium	 influx,	 through	 voltage-gated	 calcium	 channels	 or	 NMDA/AMPA	 receptors	
induce	 various	 signaling	 pathways	 138.	 Neurons	 were	 afterward	 processed	 for	
immunocytochemistry	by	staining	for	Nup358	and	AnkG.	Compared	to	control	neurons	
and	 KCl-treated	 neurons,	 treatments	 with	 either	 EGTA	 or	 APV	 rescued	 Nup358	
distribution	pattern	 and	 fluorescence	 intensity	 (Fig.	 3-13,	A).	However,	 the	KCl/CNQX-
treated	 neurons	 showed	 a	 low	 intensity	 signal	 for	 Nup358	 and	 a	 distribution	 pattern	
similar	 to	 that	of	KCl-treated	neurons.	These	 results	were	confirmed	with	quantitative	
analysis	 of	 Nup358	 total	 fluorescence	 intensity	 using	 Operetta	 high-content	 imaging	
system	 (Fig.	 3-13,	B).	At	 the	protein	expression	 level,	 a	partial	 recovery	was	observed	
when	 neurons	were	 pretreated	with	 EGTA	whereas	when	 blocking	 the	 NMDARs	with	
APV,	Nup358	protein	 expression	was	 recovered	 (Fig.	 3-13,	 C).	 Alternatively,	 the	CNQX	
treated	 neurons	 showed	 Nup358	 protein	 levels	 similar	 to	 that	 of	 the	 KCl-treated	
neurons	 (see	 Fig.	 3-13,	 C).	 Noteworthy,	 that	 the	 full-length	 isoform	 was	 completely	
absent	 in	 the	 KCl,	 however,	when	 neurons	were	 treated	with	 KCl/APV	 and	 KCl/EGTA,	
there	was	a	relatively	increased	protein	expression	of	the	full-length	isoform	of	Nup358.	
Altogether,	 these	 results	 imply	 that	 neuronal	 depolarization	 with	 KCl	 alters	 Nup358	
overall	expression,	where	the	NMDARs	and	indirectly	the	calcium	influx	are	involved	in	
triggering	this	effect.	
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Figure	3-13	|	KCl-triggered	decrease	in	Nup358	expression	is	mediated	by	NMDARs.	(A)	14	DIV	cortical	
neurons	 were	 pretreated	 with:	 EGTA	 (2mM;	 30	 min),	 APV	 (50µM;	 30	 min),	 or	 CNQX	 (40µM;	 30	 min)	
followed	by	treatment	with	KCl	(1	hr).	Immunostaining	was	conducted	for	Nup358	(green)	and	AnkG	(red).	
(Scale	bar:	10µm).	The	immunofluorescent	images	show	a	recovery	of	Nup358	signal	when	neurons	were	
treated	with	EGTA	or	APV	prior	to	KCl.	(B)	Measurements	of	Nup358	total	fluorescence	intensity	(Nup358	
total	 Fl.	 Int.)	 using	 Operetta	 high-content	 imaging	 system	 showing	 Nup358	 intensity	 values	 similar	
between	 the	 control	 neurons	 and	 the	 neurons	 pretreated	with	 either	 EGTA	 or	 APV;	 additionally,	when	
compared	to	the	KCl-treatment,	both	EGTA	and	APV	significantly	recovered	the	KCl-dampening	effect	of	
Nup358	 fluorescence.	 Bars	 indicate	 means	 ±SD	 and	 wherever	 demonstrated	 (*),	 or	 (ns)	 represent	
significant	 values	 of	 p<0.05	 or	 not	 significant	 values,	 respectively.	 (C)	 Nup358	 immunoblot	 for	 14	 DIV	
cortical	neurons	treated	with	KCl,	and/or	EGTA,	APV,	and	CNQX;	with	Actin	serving	as	the	loading	control.	
The	arrows	of	Nup358	point	to	the	two	isoforms	of	Nup358,	the	full-length	and	the	short	isoforms.		(-)	or	
(+)	marks	are	used	to	indicate	where	KCl	was	included	or	not	in	the	treatment.		
3.9. Nup358	localization	at	the	AIS	does	not	depend	on	actin-microtubule	
cytoskeleton	
Nup358	is	present	at	the	nuclear	rim	and	the	cytoplasm	through	the	association	
with	NPCs	 81	and	the	ER,	 respectively	 (see	Fig.	3-1	&	Fig.	3-2).	As	 the	AIS	 represents	a	
physical	and	physiological	barrier	 for	the	mobility	of	molecules	and	proteins	at	the	AIS	
126,144,	the	high	density	of	Nup358	protein	at	this	region	suggests	a	possible	association	
with	 the	 AIS	 cytoskeleton.	 This	 hypothesis	 was	 evaluated	 through	 testing	 Nup358	
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resistance	to	non-ionic	detergent	extraction.	Being	insoluble	to	detergent	extraction	is	a	
characteristic	feature	of	most	AIS	proteins,	due	to	either	their	direct	association	with	the	
AIS	cytoskeleton	or,	 indirectly,	 through	the	 interaction	with	scaffolding	proteins	at	this	
region	144,145.	 	To	this	end,	14	DIV	mature	neurons	were	treated	with	1%	Triton	before	
being	 fixed	 and	 immunostained	 for	 Nup358	 and	 AnkG;	 the	 results	 show	 persistent	
staining	 for	Nup358,	 as	well	 as	 for	AnkG,	 indicating	 a	 potential	 interaction	of	Nup358	
with	 the	 detergent-resistant	 AIS	 cytoskeleton/scaffolds	 (Fig.	 3-14,	 A).	 As	 a	 positive	
control,	 detergent-extracted	 neurons	 were	 incubated	 with	 phalloidin,	 for	 identifying	
filamentous	actin	whose	signal	was	significantly	decreased	(Fig.	3-14,	A;	lower	panel).	
Given	 the	 importance	 of	 the	 neuronal	 cytoskeleton	 in	 maintaining	 the	 AIS	
function	 146,147,	 I	examined	whether	altering	actin	 filaments	 integrity	by	cytochalasin	D	
(Cyto	D)	or	disrupting	microtubule	polymerization	by	nocodazole	(Noc)	would	affect	the	
clustering	of	Nup358	at	the	AIS.	While	Cyto	D	treatment	was	sufficient	to	disrupt	actin	
filaments	 in	 14	 DIV	 neurons,	 proved	 by	 the	 decrease	 in	 phalloidin	 staining	 when	
compared	 to	 control	 neurons	 (vehicle),	 Nup358	 signal	 intensity	 at	 the	 AIS	 was	
remarkably	unaffected	(Fig.	3-14,	B).	In	the	same	way,	disrupting	neuronal	microtubules	
with	Noc	did	not	alter	the	distribution	nor	the	expression	of	Nup358	at	the	AIS	(Fig.	3-14,	
C).	 These	 observations	 were	 further	 confirmed	 by	 the	 quantitative	 analysis	 using	
Operetta	 high-content	 imaging	 system,	 that	 showed	 no	 difference	 in	 Nup358	
fluorescence	intensity	between	Cyto	D-	or	Noc-treated	neurons	and	the	control	neurons	
(vehicle)	 (Fig.	3-14,	D).	Altogether,	 these	 results	 imply	 that	Nup358	 localization	at	 the	
AIS	 is	 not	 dependent	 on	 actin-MT	 neuronal	 cytoskeleton.	 Further,	 these	 data	 thus	
suggest	that	Nup358	is	associated	with	an	AIS	scaffold	protein,	most	likely	AnkG.		
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Figure	3-14	|	Nup358	clustering	at	the	AIS	is	not	dependent	on	the	actin-microtubule	cytoskeleton.	(A)	
14	 DIV	 cortical	 neurons	 were	 treated	 with	 1%Triton	 in	 a	 cytoskeletal	 buffer	 before	 being	 fixed	 and	
immunostained	for	Nup358	(green)	and	AnkG	(red).	Control	neurons	were	labelled	instead	for	Actin	using	
phalloidin	 staining	 (red).	 In	 both	 sets	 of	 images,	Nup358	 signal	was	 persistent	 at	 the	AIS	 as	well	 at	 the	
nuclear	rim,	most	likely	due	to	its	association	with	NPCs.	(B)	neurons	were	treated	for	1	hr	with	Cyto	D	(10	
μM;	 1	 hr);	 disruption	 of	 actin	 filaments	was	monitored	 by	 phalloidin	 staining	 (red).	 (C)	 Depolymerizing	
microtubules	 was	 conducted	 by	 treatment	 with	 Noc	 (20	 μM;	 3	 hr),	 followed	 by	 fixation	 and	
immunolabeling	with	the	microtubule	marker	βIII-tubulin.	In	both	(B)	and	(C),	DMSO	incubation	was	used	
as	 control	 (vehicle).	 (Scale	 bar:	 10µm).	 (D)	Quantitative	 analysis	 of	Nup358	 total	 fluorescence	 intensity,	
and	 at	 the	 level	 of	 the	 somatodendritic	 compartment	 and	 the	 AIS	 region,	 where	 results	 were	 almost	
identical	with	no	significant	difference	between	the	CytoD-	or	Noc-treated	neurons	and	the	control	ones.	
Bars	indicate	means	±SD.	
3.10. AnkG	is	required	for	Nup358	localization	at	the	AIS	
Based	 on	 the	 previous	 results	 presented	 in	 this	 study,	 I	 assumed	 that	 Nup358	
localization	at	the	AIS	of	mature	neurons	is	dependent	on	AnkG,	probably	 in	a	manner	
similar	to	other	AIS	proteins	135,136,148.	AnkG	is	known	to	be	the	master	scaffold	protein	
present	 at	 the	 AIS	 that	 orchestrates	 the	 clustering	 of	 other	 AIS	 protein	 including	Nav	
channels,	 KCNQ2/3,	 βIV-spectrin,	 and	 NrCAM	 (neuron-glia	 related	 cell	 adhesion	
molecule)		135,149.		
To	investigate	the	interdependence	between	Nup358	and	AnkG	for	association	at	
the	 AIS,	 either	 proteins	were	 downregulated	 using	 RNAi	method	 of	 GFP-coexpressing	
shRNA	 plasmids.	 As	 controls,	 neurons	 were	 transfected	 instead	 with	 a	 non-targeted	
shRNA.	Transfections	were	conducted	on	5	DIV	mouse	cortical	neurons,	afterward	 the	
medium	was	changed	and	neurons	were	maintained	up	to	10	DIV.	Immunostaining	was	
carried	out	with	Nup358	and	AnkG	antibodies.	Regarding	transfection	with	the	control	
shRNA,	neurons	demonstrated	no	change	in	Nup38	distribution	profile	or	AIS	assembly;	
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this	was	manifested	 by	 the	 normal	 staining	 of	 both	Nup358	 and	 AnkG	 (Fig.	 3-15,	 top	
panel).	 As	 for	 assessing	 the	 ability	 of	 the	 shRNA	 in	 eliminating	 the	 expression	 of	 the	
target	 protein,	 the	 results	 show	 transfected	 neurons	 with	 a	 reduced	 signal	 of	 the	
corresponding	protein.	While	as	for	testing	the	 interdependence	between	Nup358	and	
AnkG,	 the	 results	 presented	 here	 show	 that	 upon	 downregulating	 AnkG,	Nup358	was	
not	recruited	to	the	AIS	region	but	present	at	the	nuclear	rim	and	in	the	cell	soma,	thus,	
proving	 the	 essential	 role	 of	 AnkG	 in	 the	 clustering	 of	 Nup358	 at	 the	 AIS	 (Fig.	 3-15,	
middle	panel).	However,	surprisingly,	Nup358	depleted	cells	exhibited	a	dramatic	loss	of	
AnkG	signal	compared	to	untransfected	cells	 (Fig.	3-15,	bottom	panel),	suggesting	that	
Nup358	influences	AnkG	enrichment	and/or	stability	at	the	AIS.	Taken	together,	AnkG	is	
a	 key	 scaffold	 for	 the	 recruitment	 of	 Nup358	 and	 other	 AIS	 proteins	 at	 this	 region,	
however	its	long-term	stability	at	the	AIS	might	be	related	to	a	possible	interaction	with	
Nup358.	
	
Figure	 3-15	 |	 Nup358-AnkG	 interdependence	 for	 enrichment	 at	 the	 AIS.	 Cortical	 neurons	 were	
transfected	at	5	DIV	with	shRNA	constructs	co-expressing	GFP	to	downregulate	AnkG	(shAnkG)	or	Nup358	
(shNup358)	and	maintained	afterward	in	culture	up	to	10	DIV.	As	control,	neurons	were	transfected	with	
non-targeted	 shRNA	 construct	 (shCtrl).	 Immunostaining	 was	 conducted	 for	 both	 AnkG	 (magenta)	 and	
Nup358	 (red).	 Asterisks	 are	 used	 to	 mark	 the	 transfected	 neuronal	 cells	 (green)	 with	 a	 substantial	
decrease	in	both	AnkG	and	Nup358	signals	compared	to	the	control	untransfected	cells.	(Scale	bar:	10µm). 
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4. DISCUSSION	
Nup358	 was	 initially	 described	 as	 a	 giant	 protein	 residing	 on	 the	 cytoplasmic	
filaments	of	the	NPC	81,82.	The	classical	role	of	this	nucleoporin	 is	then	to	contribute	 in	
the	overall	function	of	the	NPC	mediating	nucleocytoplasmic	transport;	yet	a	few	studies	
have	 identified	Nup358	 in	the	cytoplasm	of	various	cell	 types.	Since	then,	the	dynamic	
behavior	of	this	nucleoporin	has	been	under	the	spotlight	for	subsequent	investigations	
and	in	various	cellular	contexts	including	neuronal	cells	107,110,118,120.		
In	this	thesis,	the	key	aim	was	to	examine	Nup358	role	during	the	in	vitro	development	
of	neurons	that	include	establishing	and	maintaining	neuronal	polarity.	As	Nup358	was	
identified	 in	 the	 AIS	 of	 mature	 neurons,	 the	 central	 theme	 of	 the	 study	 was	 shifted	
towards	 addressing	 its	 clustering	 at	 this	 specific	 region	 and	 association	 with	 the	 AIS	
architecture.	 Further,	 I	 investigated	 the	 correlation	 between	 Nup358	 and	 altered	
neuronal	activity.	
4.1. Unique	subcellular	distribution	of	Nup358	in	cultured	cortical	neurons	
In	 mature	 cortical	 neurons,	 Nup358	 has	 a	 distinctive	 tripartite	 distribution	
pattern:	 present	 at	 the	 nuclear	 rim	 associated	 with	 NPCs,	 at	 the	 ER	 in	 the	 form	 of	
discrete	spots,	and	clustered	at	the	AIS	(Fig.	3-1).	At	the	nuclear	rim,	Nup358	localization	
was	fairly	expected;	however,	instead	of	having	a	punctate	pattern	relative	to	the	NPCs	
traversing	 the	 NE	 at	 specific	 intervals	 (see	 Fig.	 1-1),	 Nup358	 formed	 an	 almost	
continuous	 ring	 around	 the	nucleus.	 This	 is	 likely	 attributed	 to	 the	high	 abundance	of	
NPCs	present	in	cultured	neurons	at	this	stage	of	development.	And	what	supports	this	
view	 is	 the	 similar	 trend	 observed	 when	 neurons	 were	 immunostained	 for	 different	
nucleoporins	 (Fig.	 3-3).	 As	 the	 main	 role	 of	 NPCs	 is	 to	 mediate	 RNA	 and	 protein	
trafficking	in	neurons,	the	high	abundance	of	NPCs	in	14	DIV	neurons	might	be	linked	to	
the	 relative	metabolic	activity	of	cultured	neurons.	This	 link	between	NPCs	abundance	
and	metabolic	activity	would	need	future	investigations	as	little	is	known	in	this	regard	
115	 and	 generally	 little	 attention	 has	 been	 paid	 to	 the	 metabolic	 activity	 of	 cultured	
neurons	150.		
As	for	Nup358	distribution	in	the	cell	soma,	previous	reports	addressing	Nup358	
localization	 pattern	 showed	 that	 Nup358	 associates	 with	mitochondria	 in	 retinal	 cells	
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102,115.	However,	 in	 our	model	 of	 cortical	 and	hippocampal	 neurons,	Nup358	 is	 absent	
from	both	the	Golgi	apparatus	and	mitochondria	(Fig.	3-2).	Mitochondria	staining	in	14	
DIV	 cortical	 neurons	 shows	 most	 COX1	 fluorescence	 signal	 in	 regions	 that	 resemble	
dendritic	 protrusions	 (Fig.3-2,	 C),	 instead	 of	 being	 concentrated	 in	 the	 cell	 soma	 as	
commonly	 known.	 This	 might	 be	 related	 to	 the	 developmental	 stage	 of	 neurons	
including	synapses/spines,	and	the	movement	of	mitochondria	to	dendritic	protrusions	
to	accommodate	for	an	increased	energy	requirements	at	specific	sites	151.	Above	all,	at	
14	DIV,	neurons	are	considered	mature	and	already	established	synaptic	contacts.		
While	Nup358	signal	does	not	overlap	with	that	of	the	mitochondria	or	the	Golgi	
apparatus,	 the	 opposite	 is	 true	with	 the	 ER	 signal.	 Localization	 at	 the	 ER	 is,	 however,	
specific	 for	Nup358	among	other	nucleoporins	 that	 show	 restricted	 localization	 at	 the	
NPC	with	a	trace	signal	present	in	the	cell	soma	(Fig.	3-3).	In	fact,	this	result	contradicts	
with	 a	 previous	 report	 claiming	 the	 presence	 of	 Nup358	 together	 with	 other	
nucleoporins	 in	 the	 annulate	 lamellae	 of	 neurons	 152.	 Annulate	 lamellae	 (AL)	 are	
membranous	 organelles	 that	 carry	 characteristic	 features	 of	 both	 the	 endoplasmic	
reticulum	and	NPCs.	These	AL	structures	are	thought	to	be	a	reservoir	for	NPCs	and	are	
abundant	in	fast-growing	cells	to	retrieve	NPCs	during	cell	division.	Regarding	neurons,	
there	is	controversy	whether	AL	structures	exist	in	such	post-mitotic	cells.	According	to	
the	data	presented	here,	nucleoporins-apart	from	Nup358-are	barely	detected	in	the	ER,	
thus	supporting	the	views	against	the	presence	of	AL	in	neurons.	Instead,	these	findings	
imply	that	the	association	with	the	ER	is	a	unique	feature	of	Nup358	among	the	rest	of	
nucleoporins.	Nup358	presence	at	the	ER	might	supply	neuronal	cells	with	 in	response	
to	 physiological	 changes.	 Alternatively,	 Nup358	 might	 be	 serving	 as	 a	 chaperone	 for	
specific	proteins	to	the	ER.	In	the	neuroretina,	for	instance,	Nup358	protein	interact	with	
the	 red	and	green	opsin	 and	modulate	 their	 subcellular	 localization	 in	photoreceptors	
116.		
4.2. Two	Nup358	isoforms	
One	major	finding	of	this	study	was	identifying	two	isoforms	of	Nup358	protein	
in	 neurons.	 Given	 that	 there	 is	 only	 one	 reported	 protein	 coding	 sequence	 for	 this	
gigantic	 protein,	 previous	 studies	 have	detected	Nup358	 at	 varying	molecular	weights	
with	 no	 profound	 explanation	 about	 this	 discrepancy.	 My	 results	 of	 immunoblotting	
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samples	of	cortical	neurons	cultured	for	different	periods,	or	alternatively	homogenates	
of	mouse	cortices	obtained	at	different	ages,	exhibit	a	gradual	increase	in	a	230	kDa	MW	
isoform	 of	 Nup358	 whereas	 an	 opposite	 decrease	 was	 observed	 in	 the	 full-
lengthNup358	(Fig.	3-5).	Further,	the	same	trend	for	each	isoform	was	observed	in	the	
hippocampus	and	the	spinal	cord	during	their	development	(Fig.	3-7,	B)	thus	implying	a	
general	trend	for	expression	of	Nup358	isoforms	in	the	central	nervous	system.		
Based	on	the	results	of	mass	spectrometry	analysis	where	the	230	kDa	band	was	
identified	together	with	other	AIS	proteins,	 it	 is	more	likely	that	the	shorter	 isoform	of	
Nup358	 is	 the	 isoform	 to	 be	 clustered	 at	 the	 AIS.	 Further,	 the	 results	 of	 nucleo-
cytoplasmic	fractionation	of	neuronal	lysate	showed	an	enrichment	of	the	short	isoform	
in	the	cytoplasmic	fraction	while	the	full-length	Nup358	was	predominant	in	the	nuclear	
fraction	(Fig.	3-6,	C).	Moreover,	the	increased	expression	of	the	short	isoform	correlates	
with	the	recruitment	of	Nup358	at	 the	AIS	of	mature	neurons	 (Fig.	3-5,	A-E).	All	 these	
data	are	accumulating	evidence	that	 the	shorter	 isoform	Nup358,	 rather	 than	the	 full-
length	isoform,	is	enriched	at	the	AIS.		
Noteworthy	 that	 at	 an	 early	 stage	 of	 development,	 both	 the	 cortex	 and	 the	
hippocampus	have	a	 lower	expression	of	 the	shorter	 isoform	Nup358,	as	compared	to	
the	spinal	cord.	(Fig.	3-7,	A).	This	variation	might	be	related	to	physiological	differences	
between	 tissues	 of	 the	 CNS	 such	 as	 differences	 in	 the	 AIS	 length	 among	 neurons	
obtained	from	each	of	the	hippocampus,	cortex	and	the	spinal	cord.	Moreover,	since	the	
protein	composition	of	the	AIS	and	the	nodes	of	Ranvier	are	very	similar,	Nup358	might	
be	 present	 at	 these	 regions	 as	 well	 and	 therefore	 the	 shorter	 isoform	 of	 Nup358	 is	
consequently	 increased	 in	 expression	 in	 the	 long	 axon	 of	 motoneurons.	 Whether	
Nup358	 is	 present	 at	 nodes	of	Ranvier	 or	 that	motoneurons	has	 longer	AIS	 and	more	
nodes	 than	pyramidal	neurons	are	 key	questions	 to	address	 in	 the	 future	 for	 a	better	
understanding	about	the	behavior	of	Nup358	in	different	regions	of	the	CNS.	Indeed,	it	
was	 previously	 reported	 that	 the	 loss	 of	 Nup358	 in	 motoneurons	 causes	 the	
development	 of	 ALS-like	 syndrome;	 however,	 ALS-like	 symptoms	 were	 justified	 as	 a	
result	 of	 disrupted	 nucleocytoplasmic	 transport	 103.	 With	 the	 current	 data	 showing	
Nup358	 present	 at	 the	 AIS	 and	 further	 suggesting	 its	 presence	 at	 nodes	 of	 Ranvier,	
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Nup358	could	be	directly	 linked	to	neuronal	excitability	and	therefore	be	 implicated	 in	
neurological	diseases.		
Regarding	the	two	isoforms	observed,	based	on	the	data	presented	in	this	thesis,	
we	cannot	derive	certain	conclusions	how	the	shorter	 isoform	of	Nup358	 is	produced;	
yet	some	speculations	can	be	made	that	need	to	be	supported	by	future	experiments.	
One	attractive	scenario	would	be	the	presence	of	a	switch	 in	expression	of	Nup358	as	
neurons	 develop,	 where	 the	 shorter	 isoform	 is	 the	 predominant	 isoform.	 As	 many	
factors	 play	 role	 either	 positively	 or	 negatively	 to	 finely	 tune	 neuronal	 development,	
trans-acting	 factors	 could	 be	 one	 element	 that	 leads	 to	 this	 switch	 in	 expression	 of	
Nup358	 isoforms.	 As	 a	 result,	 the	 possibility	 of	 having	 a	 spliced	 variant	 at	 advanced	
stages	 of	 neuronal	 development,	 encoding	 for	 the	 shorter	 isoform,	 would	 then	 be	
plausible.	 To	 get	 an	 answer	 for	 such	 a	 speculation,	 whether	 the	 production	 of	 the	
shorter	 isoform	 is	 due	 to	 a	mRNA	 splicing	 event,	 better	 understanding	 of	 the	mRNAs	
encoding	both	 isoforms,	 through	northern	blotting	 technique,	would	be	helpful	 in	 this	
case.	
4.3. Nup358,	a	new	player	in	the	AIS	architecture	
	 The	AIS	is	a	unique	highly-specialized	region	of	the	neuron	morphology	that	has	a	
central	 role	 in	 establishing	 neuronal	 polarity	 and	 modulating	 their	 excitability.	 	It	
represents	the	site	for	synaptic	input	integration	and	action	potential	initiation.	The	AIS	
thus	functions	as	both	a	physiological	and	physical	bridge	between	the	somatodendritic	
compartment	 and	 the	 axonal	 domain	 153,154.	 Many	 reports	 have	 already	 identified	 its	
protein	composition	and	interactions	to	maintain	AIS	integrity.	The	AIS	represents	a	hub	
of	Nav	and	Kv	ion	channels,	cytoskeletal	and	scaffolding	proteins	149.	Of	the	AIS	proteins,	
AnkG	 is	 the	 master	 regulator	 of	 the	 AIS	 architecture,	 essential	 for	 the	 AIS	 assembly,	
clustering	of	other	AIS	proteins	and	mediating	their	stability	at	this	region	134,136	
In	this	study,	Nup358/RanBP2	has	been	identified	in	the	AIS	(Fig.	3-1).	Since	AnkG	
is	 of	 the	 early	 proteins	 that	 mark	 the	 AIS	 formation	 and	 is	 a	 key	 scaffold	 for	 the	
clustering	 of	 other	 AIS	 proteins,	 subsequent	 experiments	 were	 done	 to	 study	 the	
temporal	 expression	 of	 Nup358	 relative	 to	 AnkG.	 Remarkably,	 as	 neurons	 develop	 in	
vitro,	 Nup358	 clustering	 at	 the	 AIS	 lags	 behind	 that	 of	 AnkG;	 in	 other	 words,	 AnkG	
presence	at	the	AIS	might	then	drive	the	concentration	of	Nup358	to	this	exact	region	
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(Fig.	3-5).	Besides	 that,	experiments	were	done	to	assess	how	Nup358	associates	with	
the	AIS	architecture	by	disrupting	actin	cytoskeleton	or	microtubule	polymerization.	 In	
either	case,	Nup358	localization	at	the	AIS	was	unaffected	thus	suggesting	an	interaction	
with	an	AIS	scaffold	such	as	AnkG	(Fig.	3-14,	B	and	C).	Moreover,	AnkG	was	 identified	
with	Nup358	upon	the	immunoprecipitation	the	of	Nup358	(Fig.	3-6,	A	and	B).	Thus,	an	
interplay	between	Nup358	and	AnkG	could	be	a	result	of	either	a	direct	interaction	or	an	
indirect	 one	 modulated	 by	 another	 AIS	 protein.	 The	 hypothesis	 of	 Nup358-AnkG	
modulation	was	 supported	by	 the	downregulation	experiments	 showing	a	decrease	 in	
Nup358	 expression	 at	 the	 AIS	 when	 AnkG	 was	 downregulated	 (Fig.	 3-15).	 However	
surprisingly,	depletion	of	Nup358	resulted	 in	AnkG	loss	from	the	AIS	region	(Fig.	3-15).	
Most	AIS	proteins	are	dependent	on	AnkG	for	their	association	with	the	AIS	whereas	it	
was	 recently	 reported	 that	 AnkG-membrane	 partners,	 Nav	 channels	 and	 neurofascin-
186,	influence	the	stability	of	AnkG	during	the	formation	or	maintenance	of	the	AIS	155.	
Probably	in	the	same	manner,	even	though	AnkG	precedes	Nup358	to	recruit	at	the	AIS,	
Nup358	is	essential	for	the	long-term	stability	of	AnkG	at	this	region;	thus,	suggesting	an	
interdependence	between	both	proteins	for	localization	at	the	AIS.	Further	experiments	
would	 be	 needed	 to	 investigate	whether	 Nup358	 and	 AnkG	 are	 physically	 interacting	
with	each	other	or	that	there	is	another	mediator	involved	in	this	context.					
	 Thus,	in	terms	of	function,	Nup358	might	serve	as	a	scaffold	for	AnkG	and	other	
AIS	 proteins,	 however,	 Nup358	 might	 be	 involved	 in	 neuronal	 activity	 as	 well.	 Upon	
stimulating	 neurons	 with	 4-AP	 alone	 or	 when	 in	 combination	 with	 BIC,	 the	 overall	
expression	 of	 Nup358	 was	 decreased	 (Fig.	 3-10	 and	 3-11),	 while	 at	 the	 AIS	 Nup358	
remained	almost	unchanged.	Alternatively,	when	neurons	were	depolarized	with	KCl,	a	
major	reduction	in	Nup358	was	detected	at	the	AIS	and	in	the	entire	neuronal	cell	(Fig.	
3-12).	 While	 some	 treatment	 affect	 the	 expression	 of	 Nup358	 only	 at	 the	
somatodendritic	compartment,	other	treatments	affect	the	expression	of	the	total	pool	
of	Nup358	in	all	subcellular	regions.	This	is	a	consequence	of	the	different	mechanisms	
induced	by	each	treatment	where	the	KCl-treatment	induces	calcium	influx	mediated	by	
NMDARs,	and	substantially	affects	the	mRNA	level	of	Nup358.	 
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4.4. Insight	into	the	N-terminus	domain	of	Nup358	
As	already	demonstrated,	the	transient	expression	of	the	construct	encoding	the	
amino	terminus	region	of	Nup358	resulted	in	its	localization	at	the	AIS,	as	well	as	in	the	
cytoplasmic	 and	 the	 perinuclear	 region.	 Whereas	 exogenous	 expression	 of	 the	 full-
length	 resulted	 in	 restricted	 expression	 at	 the	 nuclear	 rim	 (Fig.	 3-8).	 With	 this	
observation,	I	propose	that	the	N-terminus	is	an	essential	region	for	Nup358	recruitment	
to	 the	 AIS.	 Despite	 that	 the	 GFP-Nup358-FL	 construct	 encodes	 for	 Nup358	 protein	
including	the	N-terminal	region,	no	signal	was	detected	in	the	AIS.	This	perhaps	implies	
that	 the	 shorter	 isoform	 lacks	 the	 sequence	 responsible	 for	 restricting	 Nup358	
localization	to	the	nuclear	rim	thus	Nup358	has	a	more	dynamic	behavior	in	neurons	and	
consequently	is	capable	of	clustering	at	the	AIS.				
Most	AIS	protein,	such	as	Nav	and	Kv	channels	contain	ankyrin	repeat	sequences	
that	 promote	 their	 interaction	with	 AnkG	 and	 association	with	 the	 AIS.	 However,	 the	
presence	of	ankyrin	 repeats	 is	not	crucial	 for	 localization	at	 the	AIS	such	as	AnkB,	one	
protein	of	the	ankyrin	family,	which	is	not	present	at	the	AIS	region	but	rather	located	in	
the	distal	region	of	the	axon	156.	 In	this	regard,	Nup358	amino	acid	sequence	does	not	
include	such	repeats	though	is	capable	of	recruitment	to	the	AIS.	Following	this	further,	
some	AIS	proteins	such	as	AnkG	are	associated	with	the	AIS	due	to	a	post-translational	
modification	 as	 S-palmitoylation	 157,158,	 hence	 are	 capable	 of	 binding	 to	 the	 plasma	
membrane.	 Interestingly,	Nup358	 protein	 sequence	 contains	 consensus	 sequences	 for	
palmitoylation	 and	 mainly	 located	 at	 the	 amino	 terminal	 region.	 Additionally,	
considering	the	different	subtypes	present	in	our	model	of	cortical	neuron	culture,	some	
neurons	displayed	 localization	of	Nup358	close	 to	 the	plasma	membrane,	especially	at	
later	developmental	period.	Despite	that	Nup358	is	known	to	be	a	soluble	protein	and	
does	not	have	transmembrane	domains	to	allow	 integration	 in	the	plasma	membrane,	
yet	Nup358	has	been	visualized	in	the	sub-membranous	region	of	the	AIS	(Fig.	3-14,	B).	
All	 in	 all,	 future	 examination	 of	 post	 translational	 modification	 on	 Nup358	 protein	
sequence	would	be	essential	in	understanding	the	mechanism	of	its	clustering	at	the	AIS	
of	cultured	neurons.		
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5. OUTLOOK	
The	 dynamic	 behavior	 of	 Nup358	 has	 been	 investigated,	 though	 poorly,	 in	
mammalian	 cell	 lines	 during	 both	 mitosis	 and	 the	 interphase	 period.	 In	 this	 thesis,	
Nup358	behavior	has	been	examined	 in	a	neuronal	 context.	Cortical	 and	hippocampal	
neurons	 show	 a	 unique	 subcellular	 distribution	 of	 Nup358	 that	 is	 not	 limited	 to	 its	
association	with	NPCs.	Nup358	is	present	associated	with	the	ER	and	most	importantly,	
Nup358	clusters	at	the	AIS	of	mature	neurons.	This	localization	at	the	AIS	correlates	with	
neuronal	 development	 and	 dependent	 on	 AnkG	 recruitment	 at	 this	 region.	 However,	
there	 is	 an	 interplay	 between	 Nup358	 and	 AnkG	 for	 localization	 and/or	 long-term	
stability	 at	 the	 AIS.	 The	 protein	 sequence	 of	 Nup358	 harbors	 multiple	 functional	
domains,	 capable	 of	 interacting	 with	 specific	 proteins.	 In	 this	 regard,	 the	 N-terminus	
region	 of	Nup358	 is	 crucial	 for	 clustering	 at	 the	AIS.	Moreover,	Nup358	 exists	 as	 two	
isoforms	in	neuronal	cells;	each	isoform	follow	a	certain	trend	relative	to	the	stages	of	
development.	Collectively,	 these	results	underscore	a	non-classical	distribution	pattern	
of	Nup358	in	neurons	with	a	focus	on	its	localization	at	the	AIS	region.	
However,	 future	 experiments	 are	 required	 to	 identify	 the	 mechanism	 of	
recruitment	 of	 Nup358	 at	 the	 AIS.	 Direct	 interaction	with	 AnkG	 or	 other	 AIS	 proteins	
might	 be	 one	 possibility.	 Additionally,	 post-translational	 modifications	 such	 as	
palmitoylation	 might	 also	 influence	 this	 specific	 localization.	 Concerning	 the	 two	
isoforms	detected	for	Nup358,	better	knowledge	about	the	mRNAs	encoding	for	these	
isoforms	will	give	an	 insight	about	the	production	of	the	shorter	 isoform	and	might	be	
consequently	linked	to	neuronal	development.	
As	 Nup358	 is	 present	 in	 three	 fractions	 distributed	 in	 neuronal	 cells,	 the	
localization	 in	 the	 ER	might	 be	 a	 store	 for	 Nup358	 or	 that	 it	 acts	 as	 a	 chaperone	 for	
different	AIS	proteins.	Understanding	the	dynamics	of	Nup358	is	therefore	essential	to	
gain	 knowledge	 about	 the	 non-conventional	 roles	 for	 this	 nucleoporin.	 In	 terms	 of	 its	
functional	 role	 in	 neurons,	 Nup358	 localization	 at	 the	 AIS	 might	 have	 a	 substantial	
influence	 on	 the	 overall	 activity	 of	 neurons;	 this	 aspect	 can	 be	 further	 addressed	 by	
downregulating	 Nup358	 in	 neurons	 and	 examining	 its	 consequence	 on	 the	 action	
potential	 firing.	 Overall,	 the	 present	 study	 identifies	 a	 unique	 behavior	 of	 the	
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nucleoporin	 Nup358	 in	 one	 of	 the	 most	 complex	 cells	 and	 further	 suggests	 its	
involvement	in	physiological	or	pathological	neuronal	conditions.		
 	
 
 
 
 
56 
6. MATERIALS	AND	METHODS	
While	experiments	were	conducted	by	myself,	Dr.	Alessandro	Roncador	contributed	
in	preparing	 the	primary	neuronal	 culture	and	Dr.	Antonio	Casini	prepared	 the	 shRNA-
AnkG	construct.	
  
Primary	 neuronal	 culture.	 	Cortical	 and	 hippocampal	 cultures	were	 prepared	 from	
E15	and	E17	mouse	embryos,	respectively,	using	a	previously	described	method	159	with	
some	modifications.	Briefly,	cortices	or	hippocampi	were	dissected	from	C57BL/6	mouse	
brains	and	treated	with	papain	solution	[papain	(20	U,	Worthington),	EDTA	(5	mM),	and	
Cysteine	(30	mM)	in	1X	Earle’s	Balanced	Salt	Solution	EBSS	(Gibco)]	for	about	20	min	in	a	
37˚C	 water	 bath,	 with	 occasional	 swirling	 of	 the	 mixture.	 Complete	 dissociation	 of	
neuronal	 cells	 was	 achieved,	mechanically,	 by	 gentle	 trituration	 through	 a	 serological	
pipette.	DNase	 I	 (1	mg/ml,	Sigma)	was	added	to	the	neuron	suspension	and	 incubated	
for	 3	min	 at	 37˚C.	 Then,	 cells	were	pelleted	 at	 1,000	 xg	 for	 5	min,	 resuspended	 in	 an	
EBSS	solution	supplemented	with	bovine	serum	albumin	(10	mg/ml,	Sigma)	and	trypsin	
inhibitor	 (10	mg/ml,	 Sigma),	 and	 centrifuged	 again	 at	 1,000	 xg	 for	 10	min.	 The	 pellet	
obtained	was	indeed	resuspended	in	Minimal	Essential	Medium	with	Glutamax	(Gibco)	
supplemented	 with	 10%	 Fetal	 Bovine	 Serum	 (FBS),	 and	 plated	 on	 poly-D-Lysine	 (10	
µg/ml,	 Sigma)-coated	 substrates.	 Cells	 were	 allowed	 to	 attach	 to	 the	 substrate	 in	 a	
humidified	37˚C,	5%	CO2	 incubator	for	24	h,	after	which	half	the	volume	of	the	culture	
medium	was	replaced	by	Neurobasal	Medium	(Invitrogen)	supplemented	with	2%	B-27	
(Invitrogen)	 and	AraC	 (5	µM,	 Sigma).	 Cultures	were	maintained	up	 to	 30	days	 in	 vitro	
(DIV),	during	which	one	half	of	the	culture	medium	was	replenished	with	fresh	growth	
medium	at	 7,	 14	 and	21	DIV.	 Rat	 hippocampal	 cultures	were	prepared	 according	 to	 a	
previously	described	protocol	160.		
Constructs.	 The	 plasmids	 used	 for	 the	 knockdown	 experiments	 were:	 scrambled	
negative	control	shRNA	(shCTRL)	and	a	pool	of	four	mouse	gene-specific	Nup358	shRNA	
constructs	(shNup358)	in	pGFP-C-shLenti	Vector	(Origene).	The	shAnkG	target	sequence,	
AGT	TCA	GAG	GAA	GTG	AGT	TAC,	was	retrieved	from	the	RNAi	Consortium	(TRC)	mouse	
shRNA	library	and	the	oligonucleotides	were	designed	according	to	the	TRC	guidelines.	
The	 annealed	 oligonucleotides	 were	 then	 cloned	 into	 a	 pLKO.1	 vector	 modified	 by	
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swapping	 the	 puromycin	 resistance	 gene	 with	 an	 EGFP	 expression	 cassette.	 For	 the	
transient	expression	of	 green	 fluorescent	protein	 (GFP)-tagged	Nup358	or	 its	different	
fragments,	the	following	constructs	were	kindly	provided	by	Prof.	Jomon	Joseph	111:	Full-
length	Nup358	 (GFP-Nup358-FL;	 1-3224	 amino	 acid	 residues),	N-terminal	 region	 (GFP-
Nup358-N;	1-900	amino	acids),	Middle-region	(GFP-Nup358-M;	901–2219	amino	acids),	
and	the	C-terminal	region	(GFP-Nup358-C;	2220–3224	amino	acids).	
Transfections.	Cortical	 neurons	were	 transfected	with	 the	 shRNA	 constructs	 using	
Lipofectamine	 LTX	 and	 Plus	 reagent	 (Invitrogen)	 according	 to	 the	 manufacturer’s	
instructions	with	few	modifications.	In	brief,	5	DIV	cultured	neurons	were	subjected	to	a	
medium	change,	though	the	old	medium	was	collected	and	kept	equilibrated	in	the	5%	
CO2	incubator	for	later	use.	In	one	tube,	1µg	of	shRNA	construct	was	diluted	in	50µl	Opti-
MEM	medium	(Gibco)	and	1µl	of	the	Plus	Reagent.	In	another	tube,	1µl	of	Lipofectamine	
LTX	 was	 diluted	 in	 50µl	 Opti-MEM.	 The	 shRNA	 &	 Plus	 mix	 was	 then	 added	 to	 the	
Lipofectamine	mixture	and	incubated	at	room	temperature	for	5	min;	this	mixture	was	
thereafter	 added	 per	 coverslip	 of	 12-well	 tissue	 culture	 plates.	 Transfections	 were	
allowed	 to	 proceed	 for	 2	 h,	 after	 which	 the	 medium	 was	 replaced	 by	 one-half	 the	
volume	 of	 fresh	 growth	 medium	 and	 another	 half	 of	 the	 old	 medium.	 Transfected	
neurons	were	maintained	in	culture	up	to	10	DIV,	then	fixed	with	4%	PFA	and	processed	
for	 immunofluorescence.	For	the	transient	expression	of	GFP-Nup358-FL,	GFP-Nup358-
N,	 GFP-Nup358-M	 and	 GFP-Nup358-C,	 transfections	 were	 performed	 using	 calcium	
phosphate	 protocol	 161.	 Rat	 hippocampal	 neurons	 were	 transfected	 at	 13	 DIV	 then	
maintained	in	culture	for	48-96	h	to	allow	expression	of	the	exogenous	protein.	Instead,	
for	 transfecting	 HeLa	 cells,	 Viafect	 reagent	 (Promega)	 was	 used	 according	 to	 the	
manufacturer’s	instructions	and	expression	was	allowed	for	48	h	in	Dulbecco’s	modified	
Eagle’s	Medium	(Gibco)	supplemented	with	10%	FBS	and	1%	Penicillin/Streptomycin	at	
37˚C	in	a	humidified	5%	CO2	incubator.	
Pharmacological	 treatments.	 To	 test	 whether	 inhibiting	 transcription	 affects	
Nup358	 distribution	 profile,	 neurons	 were	 treated	 with	 either	 actinomycin	 D	 (ActD;	
5µg/ml)	 or	DMSO	 (vehicle)	 as	 a	 control	 for	 1	 h,	 along	with	 5-Ethynyl	Uridine	 (EU;	 0.5	
mM,	Thermo	Fisher	Scientific),	a	Uracil	analog	that	gets	incorporated	into	nascent	RNA	
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during	 transcription.	 As	 for	 the	 detergent	 extraction	 experiments,	 cultured	 cortical	
neurons	were	washed	briefly	with	a	pre-warmed	HBSS,	then	incubated	with	1%	Triton	X-
100	in	the	cytoskeletal	buffer	(2	mM	MgCl2,	1	mM	EGTA,	60	mM	PIPES	buffer	pH7.0)	for	
5	min	at	37˚C,	followed	by	fixation	and	immunostaining	144.	To	study	the	association	of	
Nup358	with	 the	neuronal	 cytoskeleton,	 selected	drug	 treatments	were	carried	out	 to	
perturb	either	actin	filaments	or	microtubules.	To	depolymerize	actin	filaments,	neurons	
were	 treated	 for	 1h	 with	 cytochalasin	 D	 (Cyto	 D;10µM,	 Sigma)	 whereas	 to	 disrupt	
microtubules,	 neurons	 were	 treated	 for	 3h	 with	 nocodazole	 (Noc;	 20µM,	 Sigma).	
Alternatively,	neurons	were	 incubated	with	DMSO	alone	 (vehicle)	 to	 serve	as	negative	
control.	To	address	the	influence	of	neuronal	activity	on	Nup358	protein	expression	and	
distribution	 profile,	 the	 following	 treatments	were	 conducted	 overnight:	 Tetrodotoxin	
(TTX;	 1µM,	 Sigma),	 Bicuculline	 (BIC;	 50µM,	 Sigma),	 4-Aminopyridine	 (4-AP;	 500µM,	
Sigma),	and	in	some	cases,	neurons	were	co-treated	with	BIC	and	4-AP,	simultaneously.	
Depolarization	of	neurons	was	carried	out	for	1	h	by	adding	KCl	to	a	final	concentration	
of	50	mM	in	complete	Neurobasal	Medium	and	wherever	mentioned	the	KCl-treatment	
was	preceded	by	an	incubation	for	30	min	with	any	of	EGTA	(2mM),	APV	(100μM,	Sigma)	
or	CNQX	(40μM,	Santa	Cruz	Biotechnology).	Following	these	treatments,	neurons	were	
fixed	 and	 processed	 for	 immunocytochemistry;	 otherwise,	 neurons	 were	 lysed	 and	
prepared	 for	Western	 blotting	 or	 subjected	 to	 RNA	 extraction	 for	 qRT-PCR.	 All	 these	
treatments	were	conducted	on	14	DIV	cortical	neurons.		
Antibodies.	The	primary	antibodies	employed	 in	 immunofluorescence	 included:	
two	 closely	 related	 rabbit	 anti-Nup358	 that	 recognize	 a	 region	between	1050-1100	of	
the	amino	acid	sequence	(1:100,	Abcam	&	Bethyl),	mouse	anti-Nup88	(1:100,	Santa	Cruz	
Biotechnology),	mouse	anti-Nup98	(1:100,	Santa	Cruz	Biotechnology),	mouse	anti-m414	
(1:100,	Abcam),	mouse	anti-AnkG	(1:100,	Neuromab	&	Thermo	Fisher	Scientific),	mouse	
anti-MAP2	(1:500,	Sigma),	mouse	anti-βIII-Tubulin	(1:300,	Sigma),	mouse	anti-Golgi	P58	
(1:100,	Sigma),	mouse	anti-COX1	 (1:100,	Abcam),	mouse	anti-Calnexin	 (1:100,	Abcam),	
mouse	anti-GFAP	(1:100,	Abcam),.	The	corresponding	secondary	antibodies	were	488-,	
594-Alexa-conjugated	(1:800,	Invitrogen),	and	647-Alexa-conjugated	(1:100,	Abcam).	For	
Western	 blotting,	 the	 following	 antibodies	 were	 included:	 mouse	 anti-Nup358	 (Santa	
Cruz	Biotechnology)	against	 the	amino	acid	 sequence	1-300	of	 the	N-terminus,	mouse	
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anti-Actin	(Abcam),	mouse	anti-Nup153	(1:100,	Abcam),	mouse	anti-GAPDH	(Santa	Cruz	
Biotechnology),	rabbit	anti-β-Tubulin	(Cell	signaling),	and	goat	anti-Lamin	B1	(Santa	Cruz	
Biotechnology).		
Immunocytochemistry.	 Treated/untreated	 neurons	 were	 washed	 with	
prewarmed	HBSS	and	fixed	with	4%	PFA	for	15	min	at	room	temperature.	After	fixation,	
cells	were	rinsed	three	times	with	PBS,	5	min	each,	and	immunofluorescence	was	carried	
out	as	 follows:	neurons	were	permeabilized	with	0.1%	Triton	X-100	 in	PBS	 for	10	min,	
then	incubated	with	the	blocking	solution	(2%	BSA,	2%	FBS,	0.2%	Gelatin	in	PBS)	for	1h	
at	 room	 temperature.	 Incubation	with	 primary	 antibodies	was	 done	 overnight	 at	 4°C,	
subsequently,	 incubation	with	the	relative	Alexa	fluor-conjugated	secondary	antibodies	
was	 carried	 out	 for	 1	 h	 at	 room	 temperature.	 Phalloidin	 staining	 was	 performed	 as	
previously	described	161.	Nuclei	were	stained	with	DAPI	for	10	min;	coverslips	were	then	
mounted	using	Mowiol	and	allowed	to	dry	overnight	at	4°C.	For	the	detection	of	5-	EU	
(5-ethynyl	 uridine),	 click	 chemical	 reaction	was	 conducted	 on	 fixed	 neurons	 after	 the	
blocking	step,	using	10μM	of	the	fluorescent	label	5-FAM-Azide	(5-FAM,	Jena	Bioscience)	
in	the	following	solution	(100	mM	Tris	pH	8.5,	1	mM	CuSO4,	100	mM	ascorbic	acid)	for	
30	min.	Afterwards,	neurons	were	washed	three	times	in	TBS	buffer	with	0.5%	Triton	X-
100,	followed	by	immunostaining	for	Nup358	as	described	before.	
	Imaging.	Microscopic	analysis	was	performed	using	the	63x	oil	objective	of	the	
Zeiss	 Observer	 Z.1	 microscope,	 equipped	 with	 the	 ApoTome.2	 module.	 Images	 were	
acquired	and	processed	 into	orthogonal	projections	of	15-20	optical	z-planes	 (0.24	µm	
interval),	using	ZEN	2	imaging	software	(Zeiss).		
High-Content	 Analysis.	 Cortical	 neurons	 (60,000	 cells/well)	 were	 plated	 in	 96-
well	Cell	Carrier	plates	(PerkinElmer)	and	allowed	to	grow	up	to	14	DIV,	the	day	at	which	
drug	treatments	were	conducted.	Neurons	were	 fixed	and	 immunolabeled	 for	Nup358	
and	 AnkG	 as	 described	 previously.	 Nup358	 fluorescence	 intensity	 of	 treated	 and	
untreated	 neurons	 were	 measured	 using	 the	 Operetta	 High-Content	 Imaging	 System	
(PerkinElmer).	To	maximize	the	accuracy	of	this	quantitative	analysis,	each	condition	was	
conducted	 in	 five	 replicate	 wells,	 of	 which	 at	 least	 18	 fields	 were	 selected	 per	 well.	
Images	 were	 acquired	 using	 the	 40x	 objective,	 and	 analyzed	 with	 Columbus	 2.2	
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software.	 Neuronal	 cells	 were	 detected	 through	 nuclei	 staining	 with	 DAPI,	 and	
segmentation	 of	 the	 neuronal	 network	 was	 achieved	 by	 applying	 a	 combination	 of	
algorithmic	 parameters.	 This	 segmentation,	 therefore,	 allowed	 for	 a	 comprehensive	
analysis	 of	 Nup358	 fluorescence	 intensity	 at	 the	 level	 of	 the	 AIS	 (marked	 by	 AnkG	
staining)	 and	 the	 somatodendritic	 compartment,	 in	 addition	 to	 a	 total	 intensity	 value	
(summation	of	both	AIS	and	somatodendritic	values);	all	measurements	were	corrected	
by	subtracting	the	background	intensity.	
Western	 blotting.	 To	 analyze	 changes	 in	 Nup358	 protein	 expression	 during	
neuronal	 development,	 cultured	 neurons	 were	 collected	 at	 different	 DIV.	 Cells	were	
washed	 briefly	 with	 ice-cold	 PBS,	 then	 scraped	 and	 lysed	 in	 CHAPS	 lysis	 buffer	 [0.5%	
CHAPS	 (Sigma),	 1µM	 EDTA,	 150	 µM	 NaCl,	 50µM	 Tris-HCl	 pH	 7.4,	 10%	 glycerol,	 and	
protease	 inhibitor	 cocktail	 (Roche)].	Alternatively,	 tissues	were	dissected	 from	mice	at	
the	 embryonic	 day	 (E18)	 and	 during	 the	 postnatal	 period	 (P3-P90).	 Mouse	 cortex,	
hippocampus	 and	 spinal	 cord	 were	 isolated	 and	 homogenized	 using	 the	 same	 lysis	
buffer.	 Homogenization	 of	 tissue	 samples	 was	 conducted	 using	 a	 motor	 driven	
homogenizer	 (Heidolph),	 by	 applying	 10-15	 strokes	 at	 1,000	 RPM	 in	 a	 glass	 tissue	
grinder.	Cell	lysates	or	crude	tissue	homogenates	were	then	centrifuged	at	10,600	xg	for	
10	min	 at	 4°C.	 The	 supernatant	 of	 each	 sample	 was	 collected	 and	 equal	 amounts	 of	
protein	were	 loaded	on	a	5-8%	gradient	SDS-PAGE	gel.	Prior	to	protein	transfer	onto	a	
nitrocellulose	membrane	 (GE	Healthcare	 Sciences),	 the	 SDS-PAGE	gel	was	 rinsed	 for	 2	
min	in	the	fixing	solution	(40%	methanol,	10%	acetic	acid,	50%	Milli-Q	water).	Transfer	
was	 carried	 out	 overnight	 at	 4°C,	 at	 low	 voltage	 (40V),	 and	 immunoblotting	 was	
proceeded	 according	 to	 standard	 protocols.	 For	 the	 nucleocytoplasmic	 fractionation	
experiment,	 the	 total	 lysate	 of	 14	 DIV	 cortical	 neurons	 was	 obtained	 by	 using	 the	
previously	mentioned	buffer,	CHAPS	buffer.	Alternatively,	neurons	were	lysed	according	
to	the	protocol	137	to	isolate	the	cytoplasmic-enriched	fraction	using	STEN	buffer	and	the	
nuclear-enriched	fraction	using	RIPA	buffer.	In	all	buffers,	protease	inhibitor	cocktail	was	
included.		
Immunoprecipitation.	 Immunoprecipitation	 of	 Nup358	 was	 performed	 using	
homogenates	 of	 P30	 mouse	 cortices.	 2µg	 of	 rabbit	 polyclonal	 anti-Nup358	 was	
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incubated	with	 500µl	 of	 the	 tissue	 homogenate	 overnight	 at	 4°C,	while	 2µg	 of	 rabbit	
normal	IgG	antibody	was	used	instead	as	a	control.	Afterwards,	30µl	of	Dyna	Protein	A	
magnetic	beads	(Invitrogen)	were	washed	once	with	the	ice-cold	CHAPS	lysis	buffer	and	
incubated	 with	 the	 immunocomplex	 solution	 at	 room	 temperature	 for	 30	 minutes.	
Beads	were	then	washed	three	times	and	processed	for	Western	blotting.	
Coomassie	staining	and	mass-spectrometric	analysis.	After	gel	electrophoresis,	
staining	was	 conducted	 for	 30	min	 at	 room	 temperature	 using	 rapid	 Coomassie	 stain	
(Melford)	diluted	 in	5%	acetic	acid,	7.5%	methanol.	To	destain	 the	gel,	washings	were	
afterward	 done	 with	 5%	 acetic	 acid,	 7.5%	methanol	 solution,	 and	 repeated	 until	 the	
bands	became	visible.	Relative	to	the	protein	ladder,	the	230	kDa	band	of	Nup358	was	
identified	 in	 the	 Nup358	 immunoprecipitated	 sample,	 cut	 with	 a	 sterile	 scalpel	 and	
analyzed	by	mass	spectrometry	(Proteomic	Unit,	Cogentech).	
RNA	 isolation	 and	 qRT-PCR.	 qRT-PCR	 was	 performed	 on	 14	 DIV,	
treated/untreated	mouse	 cortical	 neurons	 obtained	 from	 three	 independent	 cultures.	
Total	 RNA	 was	 isolated	 with	 TRIZOL	 reagent	 (Thermo	 Fisher)	 and	 quantified	 using	
Nanodrop	 spectrophotometer.	 1	 μg	 of	 RNA	 was	 subjected	 to	 DNase	 I	 treatment	 and	
retro-transcribed	using	RevertAid	First	 Strand	cDNA	Synthesis	Kit	 (Thermo	Fisher).	 The	
RT	products	were	subjected	to	qPCR	amplification	of	mouse	Nup358	and	GAPDH	using	
KAPA	 SYBR	 FAST	 qPCR	 Kit	 (KAPA	 Biosystems).	 These	 samples	 were	 incubated	 in	 the	
BioRad	CFX96	Thermocycler	according	to	the	cycling	conditions:	95°C	for	3	min,	followed	
by	 40	 cycles	 of	 95°C	 for	 10	 s	 and	 60°C	 for	 30	 s,	 and	 finally	 held	 at	 4°C.	 The	 results	
obtained	 were	 analyzed	 with	 the	 Bio-Rad	 CFX	 Manager	 version	 2.1	 and	 the	 relative	
expression	 of	 mRNA	 was	 calculated	 based	 on	 the	 2−ΔΔCt	 method.	 The	 qRT-PCR	 was	
performed	in	technical	duplicate	and	biological	triplicate	of	 independent	cultures	of	14	
DIV	 mouse	 cortical	 neurons.	 For	 Nup358	 amplification,	 I	 used	 Mm.PT.58.9262525	
PrimeTime	qPCR	primers,	while	 for	GAPDH	 amplification	 I	 used	 the	primers:	mGAPDH	
forward	5’-	TTC	ACC	ACC	ATG	GAG	AAG	GC	-3’,	and	mGAPDH	reverse	5’-	GGC	ATG	GAC	
TGT	 GGT	 CAT	 GA	 -3’.	 All	 primers	 and	 probes	 used	 were	 purchased	 from	 IDT	 (TEMA	
Ricerca).	
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Statistical	 Analysis.	 All	 experiments	 were	 carried	 out	 in	 triplicates	 with	
independent	mouse	dissections.	 Immunofluorescent	 images	are	 representative	 images	
of	 at	 least	 three	 independent	 experiments.	 Results	 are	 shown	 as	 means	 ±SD,	 and	
evaluated	 by	 2-tailed	 Student’s	 t-test	 (two	 groups),	 or	 one-way	 ANOVA	 followed	 by	
Tukey’s	 test	 (more	 than	 two	 groups)	 where	 p<0.05	 was	 considered	 statistically	
significant.		
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